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Abstract
The efficacy of screening, brief, intervention, referral to treatment (SBIRT) in reducing
or eliminating methamphetamine use has not been investigated and addressed among
patients with heart failure. According to urine toxicology screens at admission at a county
hospital, approximately 50% of patients in a heart failure program were positive for illicit
substance use, and the majority of these tests (>60%) were for methamphetamine use,
one of the most cardiotoxic drugs available. This quantitative study used an existing
dataset to test the theory of intentional behavior by examining whether SBIRT
intervention increases the patient’s ability to make a behavioral change and, therefore,
makes a difference in rehospitalizations for patients with heart failure who screen positive
for methamphetamine use. Three separate logistic regression tests compared which
variables had the most influence across SBIRT or the severity of substance use on 30, 60,
and 90 days of rehospitalizations while controlling for the patients who received
screenings upon each hospital admission. The comparison between these 3 groups
indicate a relationship between severity of methamphetamine use and having a 5-time
increase in rehospitalization at 30 days. This project addresses an underresearched area
for individuals with mild and moderate substance use problems with comorbid medical
conditions. The findings may create positive social change for treatment providers by
allowing them to understand that SBIRT is a general approach and not a specific
technique. The results of this study may help health care providers such as doctors,
nurses, and health educators and social workers to assist in patient substance use recovery
and coordinate patient discharge and continuity of care following discharge.
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Chapter 1: Introduction to the Study
The current study examined intentional behavior change that related to
rehospitalizations based on the severity of methamphetamine abuse and receiving a
screening, brief intervention, and referral to treatment (SBIRT) in the Heart Failure
Program at a Santa Clara County hospital. Although I found literature on illicit substance
use and SBIRT, heart failure, and rehospitalizations, I was unable to find research that
explored the intersection of these ideas. This study has many potential social
implications. Not only will the current research serve to fill a gap in the existing
literature, but it will also illuminate the issue and the effect of SBIRT with mild to
moderate use of methamphetamine use and rehospitalization within chronic patients with
heart failure. This study is of importance to the field of social work practice as both
hospitals and primary care are moving more toward integrated behavioral health and
whole person care (Hansen et al., 2019).
In Chapter 1, I discuss the background and scope of the study. I then describe the
social problem and purpose of the study. I also introduce the research question along with
details about the nature of the study. In Chapter 2, I conduct a review of the extant peerreviewed literature. I then present all relevant existing literature regarding the topic. In
the third chapter, the methodology, I discuss my approach to this study. Chapters 4 and 5
consist of the data analysis and findings of the research.
Background
The gap in the literature that this study addresses are the links between
rehospitalizations, the effects of SBIRT, and the severity of methamphetamine use with
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patients who have chronic health conditions, particularly those who have heart
conditions. The scope of this study includes rehospitalizations and severity of
methamphetamine use with patients who have chronic health conditions and
rehospitalizations with use of SBIRT in patients with chronic health conditions,
particularly heart failure. This study is important because it contributes to the field of
physical and behavioral health and promotes an understanding of the effect of SBIRT
with mild and moderate substance use problems and comorbid medical conditions.
A vast number of physical ailments are associated with methamphetamine use,
including stroke; heart attack; damage to liver, kidney, and lungs; injuries; and death
(Darke et al., 2017). Methamphetamine use can also exacerbate several chronic medical
conditions, including hypertension and heart failure (National Institute on Drug Abuse
[NIDA], 2013; Stanford, 2009). When providers do not screen or assess for substance use
and misuse, this can compromise medical treatment in numerous ways; for example, lack
of screening can increase the risks for adverse drug interactions and hampering adherence
to medications and other treatment protocols (Paratz et al., 2016). Some people do not
know that their level of substance use is risky; education and feedback about the level of
use may be enough to motivate change (Tarango & Baird, 2018). Research relating to
SBIRT began more than 40 years ago, and multiple trials now provide evidence of
SBIRT’s effectiveness. Meta-analyses and reviews that included more than 34
randomized controlled trials of SBIRT (focused primarily on at-risk and problem
drinkers) revealed an overall 10% to 30% reduction in alcohol consumption at 12 months
(Bertholet et al., 2009; Moyer et al., 2002; Whitlock et al., 2004).
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Researchers have expanded their analysis of SBIRT to address illicit substances.
Saitz et al. (2012) acknowledge that screening, brief intervention, referral to treatment
(SBI) has been proven to be effective on unhealthy alcohol use, but there is a concern that
drug SBI may have limited or no efficacy. This three-group randomized trial tested the
efficacy of two brief counseling interventions for unhealthy drug use, a brief negotiated
interview, and adaptation of motivational interviewing compared with no-brief
intervention. Saitz et al. cautioned that brief intervention (BI) for drug use in primary care
settings due to patients discussing drug use may cause challenges as health care providers
struggle to determine between appropriate use and inappropriate use of illicit drugs. Saitz
et al. reasoned for caution in using BI for drug use, provided that researchers examine
different models of SBI that are economically sound and sustainable for those patients
who were present with different levels of motivation for change.
Roy-Byrne et al. (2014) researched whether BI improves drug use outcomes
compared with care as usual. One group received a single BI using motivational
interviewing, a handout, and a list of substance abuse resources, and a 10-minute
telephone booster within 2 weeks (Roy-Byrne et al., 2014). The other group received care
as usual, which included a handout and a list of substance abuse resources. The one-time
BI with attempted telephone booster did not affect drug use patterns in primary care
settings (Roy-Byrne et al., 2014). Although this study showed no effectiveness, this may
have been due to participants receiving only a single BI. It is important to note that
expecting risky substance use to stabilize in one or two sessions when conducting a brief
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negotiated interview is unrealistic. It is relevant to this social issue to know that multiple
sessions are often necessary (Roy-Byrne et al., 2014).
The research expanded to explore the use of SBIRT for its suitable method of
identification and intervention techniques for evidence of efficacy in reducing illicit
substance use (Dwinnells, 2015). Dwinnells’ (2015) quasi-experimental study examined
the effectiveness of the SBIRT at a community health center. The results suggest that in
an outpatient clinic, SBIRT is effective in identifying patients at risk for depression,
alcohol, and substance use. This study proved to affect the improvement of identification
and diagnosis. Despite research indicating low efficacy of BI for drug use found through
screening in the primary care setting, their studies have implications for the integration of
behavioral health with specialty care where there are major unmet health needs such as
chronic illnesses and substance abuse (Dwinnells, 2015; Saitz, 2014). Furthermore, there
is a need to explore the modification in the use of SBIRT in specialty care clinics.
Problem Statement
The link between substance use disorders and physical health is well established.
Patients who abuse alcohol and drugs are much more likely to develop medical problems
than the general population (Schulte & Hser, 2014). These patients tend to present more
frequently for medical conditions caused by or exacerbated by continued alcohol and
drug use. According to the National Survey on Drug Use and Health, the Substance
Abuse and Mental Health Services Administration (SAMHSA), reported that illicit drug
use in the United States has been increasing (United Nations Office on Drugs and Crime
[UNODC], 2017). Worldwide, approximately 37 million people use amphetamine and
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prescription stimulants. Amphetamine is the most commonly used and misused drug
second only to cannabis (UNODC, 2017). In California, 20- to 29-year-olds comprised
34% of all individuals admitted to treatment for primary methamphetamine use, and it is
the primary drug responsible for 26% of all hospital admissions (SAMHSA, 2011).
Methamphetamine is one of the most cardiotoxic drugs and can cause numerous
heart failure problems stemming from chronic drug-induced hypertension, tachycardia,
and cardiac arrhythmia (Yeo et al., 2007). It is well-established that heart failure is an
economic burden on the health care system (Diercks et al., 2008). Recognition of
methamphetamine-associated cardiomyopathy among medical caregivers is important,
given the growing use of methamphetamine. Methamphetamine use after heart surgery
often counters the medical procedures and increases recidivism back to the hospital (Yeo
et al., 2007).
Even though methamphetamine-associated problems are recognized, there is
rarely any intervention to reduce methamphetamine use and further complications
(Zgierska et al., 2014). Several research studies demonstrate the effects of SBIRT on
patient outcomes with chronic health conditions, including tobacco use and at-risk
alcohol use with chronic health care conditions (Babor et al., 2007; Glass et al., 2017;
Saitz et al., 2010; Saitz, 2014; Timko et al., 2016).
A study by Swaminathan et al. (2014) examined the effects of screening,
assessment, and BI on patients’ outcomes with chronic health conditions. This study
illuminates important findings but, after a comprehensive empirical literature search,
there is no research that examined the utility of BI for mild to moderate substance use
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disorders and the efficacy on a target population such as patients with heart failure. Given
such, further research is warranted that could examine the utility of BI for mild to
moderate substance use disorders in an effort to address the documented problem that
approximately 50% of patients with heart failure screened positive for methamphetamine
use in a heart failure program at a Santa Clara County hospital (Swaminathan et al.,
2014).
Purpose of the Study
The purpose of this quantitative study using an existing dataset was to test the
theory of intentional behavior change that relates to rehospitalizations based on severity
of methamphetamine abuse using the CAGE-AID score and receiving a SBIRT in a heart
failure program at a Santa Clara County hospital.
Research Questions
The research question for this study is as follows: Does the SBIRT intervention
increase the patient’s ability to make a behavioral change and therefore make a difference
in rehospitalizations for patients with heart failure who screen positive for
methamphetamine use?
Framework
The theoretical base for this study was the transtheoretical model (TTM).
According to DiClemente (2018), the process of intentional behavior change can be
explained through the core dimensions of the TTM. The model’s initial insight stated that
process change only happened in the framework of the stages of change. The TTM (also
called the stages of change model), developed by Prochaska and DiClemente in the late

7
1970s, evolved through studies examining the experiences of smokers who quit on their
own in relation to those requiring further treatment to understand why some people were
capable of quitting on their own (Prochaska et al., 1992). It was determined that people
quit smoking if they were ready to do so. Thus, the TTM focuses on the decision making
of the individual and is a model of intentional change. The TTM operates on the
assumption that people do not change behaviors quickly and decisively. Rather, change in
behavior, especially habitual behavior, occurs continuously through a cyclical process.
The TTM is not a theory but a model; different behavioral theories and constructs can be
applied to various stages of the model where they may be most effective.
The TTM posits that individuals move through six stages of change:
precontemplation, contemplation, preparation, action, maintenance, and termination
(Prochaska et al., 1992). Termination was not part of the original model and is less often
used in application of stages of change for health-related behaviors. For each stage of
change, different intervention strategies are most effective at moving the person to the
next stage of change and subsequently through the model to maintenance, the ideal stage
of behavior (Prochaska et al., 1992).
Precontemplation: In this stage, people do not intend to take action in the
foreseeable future (defined as within the next 6 months). People are often
unaware that their behavior is problematic or produces negative consequences.
People in this stage often underestimate the pros of changing behavior and place
too much emphasis on the cons of changing behavior.

8
Contemplation: In this stage, people are intending to start the healthy behavior in
the foreseeable future (defined as within the next 6 months). People recognize that
their behavior may be problematic, and a more thoughtful and practical
consideration of the pros and cons of changing the behavior takes place, with
equal emphasis placed on both. Even with this recognition, people may still feel
ambivalent toward changing their behavior.
Preparation (determination): In this stage, people are ready to take action within
the next 30 days. People start to take small steps toward the behavior change, and
they believe changing their behavior can lead to a healthier life.
Action: In this stage, people have recently changed their behavior (defined as
within the last 6 months) and intend to keep moving forward with that behavior
change. People may exhibit this by modifying their problem behavior or acquiring
new healthy behaviors.
Maintenance: In this stage, people have sustained their behavior change for a
while (defined as more than 6 months) and intend to maintain the behavior change
going forward. People in this stage work to prevent relapse to earlier stages.
Termination: In this stage, people have no desire to return to their unhealthy
behaviors and are sure they will not relapse. Since this is rarely reached, and
people tend to stay in the maintenance stage, this stage is often not considered in
health promotion programs.
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To progress through the stages of change, people apply cognitive, affective, and
evaluative processes. Ten processes of change have been identified, with some processes
being more relevant to a specific stage of change than others (Prochaska et al., 1992).
These processes result in strategies that help people make and maintain change.
1. Consciousness raising: Increasing awareness about the healthy behavior.
2. Dramatic relief: Emotional arousal about the health behavior, whether
positive or negative arousal.
3. Self-reevaluation: Self reappraisal to realize the healthy behavior is part of
who they want to be.
4. Environmental reevaluation: Social reappraisal to realize how their
unhealthy behavior affects others.
5. Social liberation: Environmental opportunities that exist to show society is
supportive of the healthy behavior.
6. Self-liberation: Commitment to change behavior based on the belief that
achievement of the healthy behavior is possible.
7. Helping relationships: Finding supportive relationships that encourage the
desired change.
8. Counter-conditioning: Substituting healthy behaviors and thoughts for
unhealthy behaviors and thoughts.
9. Reinforcement management: Rewarding the positive behavior and
reducing the rewards that come from negative behavior. This is where
operant conditions principle can take place.
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10. Stimulus control: Re-engineering the environment to have reminders and
cues that support and encourage the healthy behavior and remove those
that encourage the unhealthy behavior.

As DiClemente’s (2018) research progressed, it became evident that the process
of change expanded. There are two types of processes of change involved in intentional
behavior change. One type represents cognitive and experiential processes, which
involves thinking and feeling, such as consciousness-raising: gaining information that
increases awareness about the current behavior pattern or the potential for new behavior.
The second type involves an action-oriented process that involves behavioral
commitment and actions to create or break a habit such as reinforcement management:
identifying and manipulating the positive and negative reinforcers for current or new
behavior. Intentional behavior change requires creating rewards for new behaviors while
eliminating reinforcements for current behaviors.
Limitations of the TTM
There are several limitations of TTM, which should be considered when using
this theory in public health. Limitations of the model include the following:
1. The theory ignores the social context in which change occurs, such as SES
and income.
2. The lines between the stages can be arbitrary with no set criteria of how to
determine a person's stage of change. The questionnaires that have been
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developed to assign a person to a stage of change are not always standardized
or validated.
3. There is no clear sense for how much time is needed for each stage, or how
long a person can remain in a stage.
Although the model assumes that individuals make coherent and logical plans in
their decision-making process, this is not always true.
The TTM provides suggested strategies for public health interventions to address
people at various stages of the decision-making process. This can result in interventions
that are tailored (i.e., a message or program component has been specifically created for a
target population's level of knowledge and motivation) and effective. The TTM
encourages an assessment of an individual’s current stage of change and accounts for
relapse in people’s decision-making process.
The TTM provides suggested strategies such as SBIRT for public health
interventions to address intentional behavior change. The concept that makes the TTM
unique is the idea that change occurs over time, an aspect overlooked by other theories of
change (Prochaska et al., 1992). According to TTM, behavior change is treated as
progressive and continuous rather than linear. Viewing behavior change as dynamic,
nonlinear, and inherently complex is considered one of the theory’s strengths (Marshall
& Biddle, 2001). DiClemente et al. (2004) used TTM to focus their attention on the
development of a theory that would explain and organize the meaning and reasons for
intentional behavior change. The BI part of SBIRT is a strategy by which people gain
skills and confidence to help people understand and move through intentional behavioral
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change (DiClemente, 2018). The BI that was used in the heart failure study, Brief
Negotiated Interview, used motivational enhancement and cognitive behavioral
approaches to help their patients address unhealthy thoughts and behaviors associated
with current use patterns and acquire change strategies. This BI encompasses the many
concepts of intentional behavior change theory.
As applied to this study, the theoretical foundation for the efficacy of the SBIRT
is in the TTM. The TTM aspects, known as processes of change, are cognitive and
behavioral activities used to progress through intentional behavioral change (DiClemente,
2018). The TTM process of intentional behavioral change theory holds that it would
expect the independent variables, which are the severity of methamphetamine use and
receiving SBIRT, to explain or influence the dependent variable, which is the
rehospitalizations. The intentional behavior change can help a patient achieve goals of
reduction or elimination of substance use in the change process (Kennedy & Gregoire,
2009). Applying TTM in substance use and co-occurring disorders, change occurs as a
result of increasing negative consequences and their motivational influence. Motivational
interviewing (MI) is an approach to work with patient ambivalence and help them
determine their ability/capacity to change and to provide them with the skills to do this.
The SBIRT becomes the context to apply the MI treatment.
Several studies found that readiness to change was an important predictor of
response to substance use interventions (Carpenter et al., 2002). More specifically,
participants who reported greater recognition that (a) their substance use was problematic
and (b) of the need for change reported larger reductions in their post-\intervention
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substance use involvement (Bertholet et al., 2009; Carpenter et al., 2002). These studies
suggest that people are more inclined to change their substance use if they are aware that
a problem exists and recognize the need for change (Bertholet et al., 2009; Carpenter et
al., 2002; Collins et al., 2012). SBIRT is strategic in the change process by allowing
patients to become more aware of the effects of substance use disorders (SUDs), gain
skills and confidence to make intentional behavior change, and find alternatives to their
use (Roy-Byrne et al., 2014). Primary care settings provide the best context and
opportunities for change over time since patients expect preventive care and a
longitudinal relationship with a health care provider.
Nature of the Study
This study examined how SBIRT can influence rehospitalizations. This study
examined those individuals who have tested positive for methamphetamine use, who also
have a serious heart condition, and who have not sufficiently found ways to reduce their
drug use to maintain heart health. Because the literature is clear about a strong linkage
between methamphetamine use and a heart condition, in this study, avoiding
rehospitalization served as a proxy indicator for intentional behavioral change.
This is a quantitative study that utilized logistic regression to compare which
variables had the most influence comparing SBIRT or the severity of methamphetamine
use on rehospitalizations. The dependent variable (rehospitalization) is categorical
(hospitalized = 1; not hospitalized = 0). For a categorical dependent variable when there
are two or more independent variables of any type (SBIRT and CAGE-AID score),
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logistic regression is an appropriate multivariate procedure. This allowed for comparison
in relation to which independent variable has more influence on the dependent variable.
The sample size has a high power to show statistical results <.05 for a bivariate
comparison of means (mean CAGE-AID score for those rehospitalized versus those who
are not); as well as for a chi-square analysis with SBIRT as the independent variable. I
used SPSS to analyze secondary data to understand the theory of intentional behavior
change that relates to rehospitalizations and the use of SBIRT and severity of
methamphetamine use (Hosmer et al., 2013).
In total, there were 608 hospitalizations in the year 2013, which received a
primary diagnosis of HF. These hospitalizations also included patients with a left
ventricular ejection fraction (LVEF) ≤ 40%, which were categorized into systolic heart
failure. I excluded patients if they were categorized with diastolic dysfunctions only,
were unable to care for self, had no reliable caregiver, or resided in a skilled nursing
facility (SNF). Additionally, I excluded patients if enrolled in palliative care/hospice,
pending cardiac surgery, or end-stage renal disease.
The primary purpose of logistic regression is to describe data and to explain the
relationship between one dependent binary variable and one or more nominal, ordinal,
interval, or ratio-level independent variables (Hosmer et al., 2013).
Definitions
The following definitions have been provided for the terms used in this study:
Methamphetamine use is considered a substance use disorder and is defined by
the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-V) as use of nicotine,
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alcohol, and/or other drugs with two or more of the following symptoms within a 12month period: (a) attempting to cut back on substance use without success; (b)
consuming more of the substance than planned; (c) spending a lot of time and energy
getting, consuming, and recovering from using the substance, often referred to as
“craving”; (d) failing to fulfill major life obligations due to the substance use; (e)
continuing to use the substance despite consequences; (f) giving up or reducing important
activities due to substance use; (g) using in dangerous situations; (h) developing
tolerance; and (i) experiencing withdrawal (American Psychiatric Association, 2013).
Screening is defined as involving the use of specific, evidence-based
questionnaires in verbal and written formats that detect risky alcohol and drug use
(SAMHSA, n.d.). The questions asked during the screening are intended to measure
quantity and frequency of substance use over defined periods of time (SAMHSA, n.d.).
They are also designed to measure the occurrence of its adverse consequences. These
screenings are designed to be quick, lasting only five to fifteen minutes (SAMHSA, n.d.).
CAGE-AID screening is defined as early identification of substance use by using a
screening tool to alert the providers to patients who need follow-up and further
assessment of substance use patterns and their association with adverse health effects
(SAMHSA, n.d.). The CAGE-AID screens for alcohol and drug problems. Each response
is scored as 1. A score of 2 or higher is considered clinically significant and should raise
the clinician’s index of suspicion that the individual has a SUD problem or disorder
(Ewing, 1984).
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Brief intervention is be defined as a nonjudgmental encounter between a health
professional and a patient that is designed to help improve chances that the patient will
reduce risky alcohol consumption or discontinue harmful drug use (SAMHSA, n.d.). A
BI goes beyond the sharing of simple advice. Evidence-based approaches are used to give
the patient tools for changing his/her beliefs about substance use and coping with
everyday situations that exacerbate his/her risk for harmful use (SAMHSA, n.d.). Clear
directive advice involves focusing on increasing patient insight and awareness regarding
substance use, and encouraging behavioral change through MI and self-management
approaches (Miller & Rollnick, 2012).
Referral to treatment is defined as making a referral to specialized treatment for
substance use disorders for those whose screening score indicates a severe problem or
dependence or who find themselves unable to limit drinking (SAMHSA, n.d.).
CAGE-AID score is defined as each response receiving a score of 1. Score 1 is a
possible low-risk SUD. Score 2 is a probable moderate risk for SUDs or at-risk use. A
Score 3 or higher is considered clinically significant and high-risk, and should raise the
clinician’s suspicion that the individual has a SUD problem or disorder (Ewing, 1984).
Ejection fraction (EF) is defined as the measurement in determining how well the
patient’s heart is pumping out blood with each contraction and in diagnosing and tracking
heart failure (American Heart Association, n.d.).
Heart failure stage is defined as a rating system to evaluate the development and
progression of heart failure symptoms. The system includes four stages. Stages A and B
represent people who have not yet developed heart failure but are at high risk because of
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coronary artery disease, high blood pressure, diabetes, or other predisposing conditions.
Stage C includes patients with past or current symptoms of heart failure who have a
condition called structural heart disease. Stage D includes patients who have advanced
heart failure that is difficult to manage with standard treatment (Horsley, 2010).
Hospital readmissions is defined as multiple inpatient stays within a specified
time period (30-60-90 days) by the same patient (Hersh et al., 2013).
Limitations
Because I examined a patient cohort with mild-to-moderate SUD, I assumed that
they will have greater motivation for change than those patients with a severe chronic
relapsing level of SUD severity. The current retrospective study had a scope and
limitations that restricted the research questions that can be answered. Socioeconomic
issues, access to therapy, access to health care—which all contribute to the higher
incident of health risks—were beyond the scope of this study. I did not look at the severe
chronic relapsing level of SUD severity but mild to moderate SUD. Furthermore, my
sample did not consist of random sampling, but rather a census study, because I gathered
data on every member of the population. The boundaries for this study were set to
facilitate interpretation of the results and helped to arrive at meaningful conclusions.
Threats to reliability serve as study limitations. These may include the subjective
responses to CAGE-AID and participants under reporting the severity of their SUD.
Another threat could be that those patients who volunteer for treatment might be more
motivated to change than those patients who did not participate in treatment, and so the
sample may be biased.

18
Significance
This research filled a gap in understanding the links between rehospitalizations
and the effects of SBIRT and severity of methamphetamine use with patients who have
chronic health conditions (Saitz et al., 2012). This project is unique because it addressed
an under-researched area for individuals with mild and moderate substance use problems
with comorbid medical conditions. The potential for positive social change is for
treatment providers to understand that SBIRT is a general approach and not a specific
technique. SBIRT needs to be modified for use in various settings. A one-size-fits-all
approach to address substance use does not work (Zgierska et al., 2014). The results of
this study will also help health care providers such as doctors, nurses, and health
educators and social workers to assist in patient substance use recovery and coordinate
patient discharge and continuity of care following discharge (NASW, 2014).
The potential significance of this research is that it contributed to the existing
body of SBIRT literature by helping to understand how SBIRT might benefit patients
with mild to moderate methamphetamine use. It is essential to note that the efficacy of
SBIRT reducing or eliminating methamphetamine use has not been investigated and
addressed with patients with heart failure.
Summary
The current study examined the effectiveness of the use of SBIRT for the
treatment of mild-to-moderate methamphetamine use disorder. The purpose of this study
was to add to the body of knowledge on ways to treat methamphetamine use disorder and
particularly with a patient cohort who have been hospitalized for cardiac complications
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either caused by or exacerbated by continued methamphetamine abuse. SBIRT is an
evidence-based practice for the treatment of substance use disorders, and the abbreviation
SBIRT is referenced as such were defined in this chapter. The research question for this
study is: How can SBIRT reduce and/or eliminate the compulsive use of
methamphetamine in a heart failure patient population? The background information
related to this study suggested that continued compulsive methamphetamine abuse,
despite adverse medical consequences, including cardiac problems, are a complication for
patients within a hospital-based heart failure program. The nature of this study involved a
quantitative approach to examine the efficacy of SBIRT on reducing compulsive
methamphetamine abuse with these patients within hospital-based heart failure program
and thereby reducing the frequency of postdischarge complications. Specifically, I used a
quantitative multiple regression in this study. In the next chapter, I review the existing
literature on this topic.

20
Chapter 2: Literature Review
Methamphetamine is one of the most commonly abused illicit drugs in the United
States (Paratz et al., 2016; Tarango & Baird, 2018). Health care providers are constantly
faced with medical complications caused by methamphetamine (Paratz et al., 2016;
Tarango & Baird, 2018). It is established that methamphetamine use is an independent
risk factor for an increase in the severity of heart failure and cardiomyopathy (Stanford,
2009; Tarango & Baird, 2018). There has been a significant amount of research that has
identified the efficacy of the use of SBIRT for reducing the problem of alcohol use
(SAMSHA, n.d.). However, during the past 5 years, there are few research studies that
demonstrate the effectiveness for reducing illicit drug use among non-treatment-seeking
patients (Saitz, 2014). These issues warrant an exploration for the effectiveness of the use
of SBIRT for the treatment of mild to moderate methamphetamine use disorder
particularly with a patient cohort who have been hospitalized for cardiac complications
either caused by or exacerbated by continued methamphetamine abuse.
A literature review is an objective, critical summary of published research
literature relevant to a topic under consideration for research. Its purpose is to create
familiarity with current thinking and research on a topic and may justify future research
into a previously overlooked or understudied area (Creswell, 2009). To begin, I present a
review of the research strategies for locating articles for future research or examination.
Next, I present a review of the research with the presentation of seminal research and the
current state of knowledge related to methamphetamine use and heart failure, evidence of
the use of SBIRT and the treatment of substance use, and then outcomes related
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specifically to SBIRT in primary care settings. Finally, I make recommendations for
moving forward in the treatment of methamphetamine use disorder and particularly with
a patient cohort who have been hospitalized for cardiac complications either caused by or
exacerbated by continued methamphetamine abuse.
Research Strategy
I conducted a literature review by using a writing strategy that began with a focus
on the broad topic of substance abuse and SBIRT. I then narrowed the focus to
methamphetamine abuse and the use of SBIRT in primary care settings. Last, I focused
the research on patients receiving an SBIRT intervention who have been hospitalized for
cardiac complications either caused by or exacerbated by continued methamphetamine
abuse.
I conducted a literature research using the Walden University online library in
tracing back to primary sources from secondary sources. I also consulted ProQuest
Central to pursue lines of inquiry related to the study, and SAGE journals and Google
Scholar to find relevant, peer-reviewed articles. I sourced local statistical information
from the United Nations Office on Drugs and Crime National and The SAMHSA
websites.
The search began by accessing multiple databases, with limiters set for peerreviewed, full-text articles dating back to 2012. I used search engines such as PsycINFO
and SocINDEX. I used combinations of the following keywords and terms by employing
Boolean identifiers to search the aforementioned data bases: substance use; substance
abuse; methamphetamine abuse; drug addiction; drug abuse; addiction treatment;
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SBIRT; primary care; primary health care; BI; TTM; motivational interviewing;
motivational therapy; process of change; stages of change; and transtheoretical model. A
breadth of articles emerged from various authors. I used each term within each of the
three databases until I established saturation by overlapping results. Because there was no
research found examining the intersection between patients receiving an SBIRT
intervention who have been hospitalized for cardiac complications either caused by or
exacerbated by mild to moderate methamphetamine abuse, the contents of this literature
review are limited to the examination of the use of SBIRT in primary care with individual
and organizational factors independently that influence client outcomes.
Theoretical Framework
The theoretical base for this study is the TTM. The TTM began in the 1970s as an
attempt to delineate an overarching behavior change process (Migneault et al., 2005).
This health behavior change model has been used for more than 30 years. According to
DiClemente (2018), the process of intentional behavior change can be explained through
the core dimensions of the TTM. The model’s initial insight stated that process change
only happened in the framework of the stages of change. As DiClemente’s research
progressed, it became evident that the process of change expanded (DiClemente, 2018).
There are two types of processes of change involved in intentional behavior change. One
type represents cognitive and experiential processes which involves thinking and feeling,
such as consciousness raising: gaining information that increases awareness about the
current behavior pattern or the potential for a new behavior. The second type, actionoriented processes, involves behavioral commitment and actions to create or break a
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habit, such as reinforcement management: identifying and manipulating the positive and
negative reinforcers for current or new behavior. Intentional behavior change requires
creating rewards for new behaviors while eliminating reinforcements for current
behaviors.
The TTM provides suggested strategies such as SBIRT for public health
interventions to address intentional behavior change. The aspect that makes the TTM
unique is the idea that change occurs over time, an aspect overlooked by other theories of
change (Prochaska et al.,1992). In the TTM, behavior change is treated as dynamic. This
distinction is considered one of the theory’s strengths (Marshall & Biddle, 2001).
DiClemente et al. (2004) used TTM to focus their attention on the development of a
theory that would explain and organize the meaning and reasons for intentional behavior
change. The BI part of SBIRT is a strategy by which people gain skills and confidence to
help people to understand and move through intentional behavioral change (DiClemente,
2018). The BI that was used in the heart failure study, brief negotiated interview, used
motivational enhancement and cognitive behavioral approaches to help patients address
unhealthy cognitions and behaviors associated with current use patterns and adopt change
strategies. This BI encompasses the many concepts of intentional behavior change theory.
As applied to this study, the theoretical foundation for the efficacy of the SBIRT
is in the TTM. The TTM aspect known as processes of change are cognitive and
behavioral activities that people use to progress through intentional behavioral change
(DiClemente, 2018). This theory holds that it would expect the independent variables,
which are the severity of methamphetamine use and receiving SBIRT, to explain or
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influence the dependent variable which is the rehospitalizations because TTM process of
change theory involves intentional behavior change. The intentional behavior change can
help a patient achieve goals of reduction or elimination of substance use in the change
process (Kennedy & Gregoire, 2009). Applying TTM in substance use and co-occurring
disorders, change occurs as a result of increasing negative consequences and their
motivational influence. MI is an approach to work with patient ambivalence and help
them determine their ability/capacity to change and to provide them with the skills to do
this. The SBIRT becomes the context to apply the MI treatment.
Several studies found that readiness to change was an important predictor of
response to substance use interventions. More specifically, participants who reported
greater recognition that their substance use was problematic and of the need for change
reported larger reductions in their post-intervention substance use involvement (Bertholet
et al., 2009; Carpenter et al., 2002; Collins et al., 2012). These studies suggest that people
are more inclined to change their substance use if they are aware that a problem exists
and recognize the need for change (Bertholet et al., 2009; Carpenter et al., 2002; Collins
et al., 2012). SBIRT is strategic in the change process by allowing patients to become
more aware of the effects of SUD, gain skills and confidence to make intentional
behavior change, and find alternatives to use (Roy-Byrne et al., 2014). Primary care
settings provide the best context and opportunities for change with time, because patients
have an expectation of preventive care and a longitudinal relationship with a health care
provider.
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Literature Review
Methamphetamine is one of the most commonly abused illicit drugs in the United
States (Karch, 2011; UNODC, 2017). Methamphetamine is highly addictive in nature and
is difficult to cease use (NIDA, 2013; Stanford, 2009). Methamphetamine is a
psychostimulant drug. Methamphetamine causes the release of the neurotransmitters such
as dopamine, norepinephrine, and serotonin (NIDA, 2013; Stanford, 2009). The
neurotransmitters activate the cardiovascular and central nervous systems (NIDA, 2013;
Stanford, 2009). The short-term side effects of methamphetamine use include increased
energy and alertness, euphoria, the decreased need for sleep, increased sexuality, and
weight loss (NIDA, 2013; Stanford, 2009). It is metabolized more slowly than other
stimulants. The drug remains in one’s system depending on individual factors.
Methamphetamine can have a 9- to 13-hour half-life (NIDA, 2013; Stanford, 2009).
Cocaine has a half-life of approximately 30 minutes, thereby making methamphetamine a
potentially more popular drug, given the longer results it offers (Fowler et al., 2008;
NIDA, 2013; Stanford, 2009). Methamphetamine use also has negative consequences
including a dry mouth that can lead to tooth decay. Other symptoms may include chronic
adverse mood and cognitive changes, including irritability, anxiety, aggression, panic,
suspiciousness and paranoia, hallucinations, executive dysfunction, and memory
impairment (McKetin et al., 2016; NIDA, 2013; Stanford, 2009).
Methamphetamine can also exacerbate existing psychiatric symptoms (NIDA,
2013). When patients attempt to cease use, they may experience the following symptoms
such as depression, anhedonia, irritability, poor concentration/poor cognitive
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performance, increased hunger and food consumption, insomnia or hypersomnia, and
psychomotor agitation (McKetin et al., 2016; NIDA, 2013; Stanford, 2009). These
negative symptoms are associated with cessation that drives patients to continue
methamphetamine use (McKetin et al., 2016; NIDA, 2013). Furthermore, there is
currently no prescription therapy available to aid in the cessation of methamphetamine
addiction (NIDA, 2013; Stanford & Avoy, 2006). These patients tend to present more
frequently for medical conditions caused by or exacerbated by continued
methamphetamine use (NIDA, 2013).
Health care providers are frequently faced with a medical illness caused by
methamphetamine use (Kaye et al., 2007). A vast number of physical ailments are
associated with methamphetamine use, including stroke; heart attack; damage to liver,
kidney, and lungs; injuries; and death (Darke et al., 2017). Methamphetamine can also
exacerbate several chronic medical conditions, including hypertension and heart failure
(NIDA, 2013).
Because this drug was first introduced, the prevalence of methamphetamine
toxicity has increased around the world. Three different retrospective autopsy series have
been published on methamphetamine-related deaths (Logan et al., 1998). The studies
explained the manifestations of methamphetamine cardiotoxicity, with the most common
being myocardial infarction, aneurysm, and cardiomyopathy. These studies
microscopically examined the hearts of methamphetamine users, and these cases
demonstrated decompensated heart failure.
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Methamphetamine-associated cardiomyopathy was first reported in the United
States in the late 1980s (Derlet et al., 1990). It is recognized that methamphetamineassociated cardiomyopathy predominately presents as heart failure with reduced ejection
fraction (EF), with an EF of less than 40% (Richards et al., 2018). It has been
documented that the risk of hospitalization and death due to heart failure is strongly
correlated with severe cardiomyopathy (Kaye et al., 2007; Richards et al., 2018).
Methamphetamine users are at a higher risk for adverse medical outcomes (Kaye et al.,
2007; Richards et al., 2018).
According to the National Survey on Drug Use & Health ([NSDUH], 2014),
SAMHSA reported illicit drug use in the United States has been increasing. In 2015,
approximately 897,000 people, aged 12 years or older, were current users of
methamphetamine, an increase from 569,00 the prior year (UNODC, 2017). Visits to the
emergency department have also increased significantly (UNODC, 2017). Worldwide,
approximately 37 million people use amphetamine and prescription stimulants in one
form or another. Amphetamine and prescription stimulants are the most commonly used
and misused drug second only to cannabis (UNODC, 2017).
In California, 20- to 29-year-olds comprised 34% of all individuals admitted to
treatment for primary methamphetamine use, and it is the primary drug responsible for
26% of all admissions (SAMHSA, n.d.). Based on these statistics, it seems the prevalence
of heart failure from methamphetamine continues to increase and the use of
methamphetamines remains a significant problem that is expanding worldwide. These
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issues require health care providers to offer interventions targeted toward the patient’s
substance use that are tailored to each patient’s needs (Tarango & Baird, 2018).
Screening, Brief Intervention, Referral to Treatment (SBIRT)
One framework that can be used by healthcare providers in any setting for
approaching harmful substance use is the SBIRT model (SAMHSA, 2011). SAMHSA
developed the SBIRT model as a comprehensive, integrated, public health approach for
persons with substance use disorders, as well as those who are at risk of developing these
disorders (SAMHSA, 2011). Research has demonstrated SBIRT’s numerous benefits.
Specifically, SBIRT successfully reduces healthcare costs; the severity of drug and
alcohol use; risk of trauma; and the percentage of at-risk patients who do not receive
specialized substance use treatment (Quanbeck et al., 2010). SBIRT consists of three
major components:
Screening: a healthcare professional assesses a patient for risky substance use
behaviors using screening tools (Bien et al., 1993).
Brief Intervention: a healthcare professional engages a patient showing risky
substance use behaviors in a short conversation providing feedback (Bien et al.,
1993).
Referral to Treatment: a healthcare professional provides a referral to brief
therapy or additional treatment to a patient who screens in need of an increase of
services (Bien et al., 1993). SBIRT is an evidenced-based practice used to
identify, reduce, and prevent risky use, abuse, and dependence on alcohol and
drugs (Amaral et al., 2010). SBIRT is used in primary care settings and enables
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healthcare professionals to universally screen and support patients who may not
be seeking help for a substance use problem, but whose drinking or drug use may
affect their ability to successfully handle health, work, or family issues (USPSTF,
2004). The SBIRT approach aims to prevent the consequences of alcohol and
drug use for patients that may engage in risky use that do not meet the criteria for
a diagnostic level of a substance use disorder. SBIRT also helps those with the
disease of addiction enter and stay with treatment (USPSTF, 2004).
Alcohol Use Disorder
There are significant results from several review studies (Babor et al., 2007; Bien
et al., 1993; Kaner et al., 2009) and meta-analyses of randomized clinical trials (Beich et
al., 2003; Bertholet et al., 2009) that demonstrate the effectiveness of SBIRT in reducing
problematic drinking in patients presenting in primary care settings. Babor et al. (2007)
described research on the components of SBIRT conducted during the past 25 years.
These reviews discussed the development of screening tests, clinical trials of BI, and
implementation research. Based on the result of this review, BI are effective with
smokers and risky drinkers, and there is some evidence that they work well with
marijuana users. Brief treatments are effective with persons who are dependent on
alcohol, marijuana, or other drugs.
Studies have indicated that SBIRT is effective in adult primary care in reducing
risky alcohol misuse (Moyer, 2013). It is evident in the literature that providing BI for
patients with alcohol problems are effective in a variety of healthcare settings including
primary care and inpatient trauma settings (D’Onofrio & Degutis, 2002; Fleming et al.,
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1997; Gentilello et al., 1999). Experimental studies have indicated screening and BI
delivered in health care settings to have efficacy for reducing risky alcohol consumption
(D’Onofrio & Degutis, 2002; Fleming et al., 1997; Gentilello et al., 1999).
The SBIRT approach can address the continuum of care for alcohol problems.
Based on the severity of alcohol use indicated by the screening results, interventions can
be brief, or referrals can be made to traditional specialty treatment for patients (Kunz et
al., 2004). For at-risk individuals, SBIRT screen for early identification of alcohol misuse
and BI around normative use misperceptions and skills enhancement. SBIRT strategies
have demonstrated to be effective in decreasing consumption and binge drinking
(Hanewinkel & Wiborg 2005; Martens et al., 2007; Murphy et al., 2001; Toumbourou et
al. 2007). The evidence further demonstrates that SBIRT may not necessarily be
conducted and provided by physicians. Rather, SBIRT can be provided by allied health
professionals such as nurses, counselors, health educators, and peers (Marlatt, 2004).
Substance Use Disorder
Based on the limited published research on SBIRT for drugs, in 1995 the United
States Preventive Services Task Force (USPSTF) concluded that there was insufficient
evidence for the effectiveness of using an SBIRT approach for drugs. Some researchers
have cited the scarcity of validated, brief drug-screening tools and the low prevalence
rates of drug use in primary care settings, as two reasons for the of insufficient amount of
studies showing SBIRT’s effects with drugs (De Micheli et al., 2004; Saitz, 2010; Smith
et al., 2010).
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Nevertheless, there has been an increase in research as well as findings from
SAMHSA-funded SBIRT projects that have shown effective results for the use of the
SBIRT approach in reducing risky drug use (Copeland et al., 2001). Moreover, a
randomized controlled trial indicated that BI could reduce cocaine and heroin use
(Bernstein et al., 2005). Bernstein et al. (2005) studied illicit drug screening and
intervention for adults in an urgent care setting. Bernstein et al. screened 23,660 patients
from women’s health, homeless, and urgent care clinics and randomized those who
screened positive for risky cocaine or heroin use (N = 1175) to a brief negotiated
interview or received a referral list and written advice. To draw valid conclusions,
adequate follow-up is needed. Ninety-five percent of eligible subjects were enrolled, and
82% were available for follow-up. At six months, abstinence was documented among
40% of the intervention subjects and 31% of the control subjects (Bernstein et al., 2005).
Although SBI has proven effective for alcohol and drug use in some healthcare
settings and some populations, more research needs to be conducted to determine the
benefit with drug users identified in primary care settings. This study also lends to the
need for feasible and effective BI for drug use primary care settings where patients with
chronic medical conditions. In other research, BI for patients screening positive for illicit
substances such as cocaine, heroin, and amphetamine is also showing results in various
healthcare settings beyond emergency departments (Cunningham et al., 2009).
Madras et al. (2008) conducted an observational before-and-after study. Based on
small sample sizes, screening and BI were linked with reductions in the use of marijuana,
amphetamine-type stimulants, cocaine, and heroin (Madras et al., 2008). Six months after
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initially screening participants, Madras et al. found a 68% decrease in self-reported drug
use and improvement in overall health, employment, criminal justice involvement, and
housing status. This study did not control for biological outcome confirmations and relied
on self-reports (Madras et al., 2008). The study would need to caution the results due to
other explanations of decreased use besides SBI. A decrease in use can be due to selfchange or regression to the mean. Although this before-and-after, retrospective
uncontrolled study informs the question of whether drug SBI has efficacy in primary
care, it still does not establish meaningful outcomes. This study demonstrated the need
for randomized controlled trials of drug SBI in adult primary care settings to be published
in peer-reviewed literature.
Humeniuk et al. (2012) demonstrated the need for further research due to the
difficulty in comparing this study to others due to the differences in the elements of each
study presented, such as the interventions being one session, phone sessions, and use of
pamphlets. Further studies are needed given the widespread implementation of SBIRT.
The World Health Organization supported a multi-national study where it was evident
that SBIRT resulted in short-term reductions of illicit drugs such as marijuana, cocaine,
amphetamine-type stimulants, and opioids (Humeniuk et al., 2012).
Humeniuk et al. (2012) conducted a large multicenter international study. The
World Health Organization randomized a trial of a single BI in five countries. Patients
were recruited from sexually transmitted disease clinics, dental, walk-in clinics, and
community medical care sites. The findings showed minimal difference favoring the BI
group based on patients ASSIST scores. Both groups began at a global ASSIST score of
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36; the BI group had a reduced score of 30 while the control group score was reduced to
32, a 2-point difference in a scale with a maximum score of 338. The United States was
the only site where the control group had a greater decrease in the score. Some
implications to consider when interpreting these results are that the study excluded those
who have moderate to severe disorder and no biological testing.
In contrast, there is currently insufficient evidence to conclude the effectiveness
of BI for reducing illicit drug use among non-treatment-seeking populations (Saitz et al.,
2012). Saitz et al. (2012) acknowledged that SBI has proven effective for unhealthy
alcohol use, but there is a concern that drug SBI may have limited or no efficacy. The
researchers advocate for the need of drug SBI to improve drug use outcomes. They argue
that more randomized controlled trials are urgently needed. Saitz et al. cautioned BI for
drug use in general health settings due to the possibility that patients may use more than
one drug or use alcohol and another drug, making BI more complicated than it is for
alcohol use. Discussing drug use may cause challenges as clinicians struggle to
distinguish between appropriate use and inappropriate use of illicit drugs. An additional
reason for the researchers to posit that there is not sufficient evidence to support
recommendations for universal drug SBI is due to the challenge of distinguishing patients
who seek help to those identified by screening. Saitz et al. concluded BI might have
different outcomes among those seeking help versus those not seeking help. However,
after examining the reasons for caution in using BI for drug use, determining the efficacy
in primary care requires different models of SBI that are economically sound and
sustainable for those patients that present with different levels of motivation for change.
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Building on previous studies, Hersh et al. (2013) explored the influence of the
SBIRT approach effectiveness based on the intensity and frequency of the BI
intervention. Hersh et al. conducted their study in three Federally Qualified Healthcare
Centers (FQHCs). A total of 10,935 patients were screened, and 600 individuals were
recruited. Participants were randomly assigned to receive one session of BI, or two to six
sessions of BI that had elements of motivational therapy and cognitive-behavioral
therapy. Participants completed follow-up assessments every three months for one year.
The primary outcome—BI—could influence substance use, but the research findings
have been mixed.
The researchers hypothesized that the lack of efficacy for illicit drug use and more
severe alcohol use might be explained by intensity and frequency of intervention. The
multiple linked BI for illicit drug use and more severe alcohol demonstrated to be more
effective than a single session of SBIRT. The severe alcohol users and illicit drug users
responded to a more expansive intervention included elements of brief treatment (Hersh
et al., 2013). This study furthered an understanding of SBIRT’s effectiveness when
SBIRT works, for whom, and what intensity is most appropriate to substances used and
severity.
Roy-Byrne et al. (2014) researched whether the BI improves drug use outcomes
compared with enhanced care as usual. One group received a single BI using
motivational interviewing, a handout and list of substance abuse resources, as an
attempted 10-minute telephone booster within two weeks (Roy-Byrne et al., 2014). The
other group received enhanced care as usual, which included a handout and a list of

35
substance abuse resources. The one-time BI with attempted telephone booster did not
affect drug use patterns seen in safety-net primary care settings (Roy-Byrne et al., 2014).
Although this study showed no effectiveness, this may have been influenced due
to participants receiving only one single BI. Expecting risky substance use to stabilize or
remit in one or two sessions of BNI is unrealistic. Multiple sessions by the clinician are
often necessary. Brief treatment was not mentioned in this study. Second, the study
measured frequency but not the quantity of drug use in a limited measure of outcomes
(Roy-Byrne et al., 2014). Currently, there is no gold standard for quantifying problem
drug use. Researchers must find a way to measure the quantity as well as the frequency of
use.
Another study shared a similar limitation, demonstrating that all BI are not the
same and their summary characterizations in reviews may be inadequate. Gelberg et al.
(2014) preliminarily reported a randomized trial of drug SBI in primary care. The
intervention was less than five minutes of brief advice, then a video doctor repeating the
advice, and two follow-up counseling sessions. Results were a greater reduction in the
drug use days in the intervention group versus the control group, among those who used
drugs more frequently (N = 334, identified from more than 15,000 screenings; Gelberg et
al., 2014). The intervention reduced self-report drug use by two days. The validity
concerns with this study include the social desirability bias and the absence of laboratory
testing to corroborate outcomes. Participants who had two or more contacts had better
outcomes. It would benefit researchers to redefine “brief intervention” and explore how
many BI have the potential for benefiting patients (Gelberg et al., 2014).
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Moreover, a quasi-experimental study examined the effectiveness of the SBIRT at
a community health center (Dwinnels, 2015). The results suggest that in an outpatient
clinic, SBIRT is effective in identifying patients at risk for depression, alcohol, and
substance use. This study proved to influence the improvement of identification and
diagnosis, despite research indicating low efficacy of BI for drug use found through
screening in the primary care setting. Dwinnells (2015) and Saitz et al. (2012) supported
the integration of behavioral health with specialty care where there are major unmet
health needs, such as chronic illnesses and substance use.
Chronic Illness and Substance Use
Methamphetamine use can exacerbate several chronic medical conditions,
including hypertension and heart failure (NIDA, 2013; Stanford, 2009). Wijetunga, Seto,
Linday, and Schatz (2013) analyzed patients discharged from a tertiary-care hospital with
the diagnosis of cardiomyopathy over four years. More than 1,600 patients were
identified, of whom 120 had been diagnosed with substance abuse as well. Substance
abuse was documented by the patient’s clinician; the clinician’s documentation may have
underestimated the overall prevalence of methamphetamine use. There is an unclear
window during which reversibility of cardiac dysfunction can occur with the cessation of
methamphetamine. Patients with substance use have a greater prevalence of chronic
medical conditions as demonstrated in this study (Wijetunga et al., 2013). These findings
demonstrate the importance of health care professionals having the role of identifying and
helping to manage substance use to improve patient outcomes.
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Methamphetamine use complicates the effective management of heart failure and
can worsen the severity of patients’ heart condition. Yeo et al. (2007) performed a casecontrol study looking at patients less than 45 years old and discharged from a hospital
with the diagnosis of either congestive heart failure or cardiomyopathy.
Methamphetamine users had 3.7 increased odds ratio of congestive heart failure or
cardiomyopathy as compared with controls (Yeo et al., 2007). This study controlled agematched, hospitalized patients who had an echocardiogram with normal LVEF of 55% or
more and no wall-motion abnormalities. These researchers demonstrated the growing
body of evidence that the development of dilated cardiomyopathy is related to chronic
methamphetamine use.
Methamphetamine use is associated with higher rates of a chronic medical
condition (NIDA, 2013; Stanford, 2009; Yeo et al., 2007). Substance use plays a role in
the development and exacerbation of chronic medical conditions such as heart failure.
Therefore, it is important for health care practitioners to detect and address substance use
in populations with chronic health conditions such as heart failure. Finally, further
research can emphasize the importance of identifying and treating substance use in this
patient population of chronic medical conditions to improve management and long-term
outcomes of these comorbid conditions.
Summary
This study is significant because it begins to fill the information gap in the
existing literature regarding the links between rehospitalizations and the influence of
SBIRT and severity of methamphetamine use with patients who have chronic health
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conditions, specifically within patients with heart failure (Saitz et al., 2012). This study
contributes to a body of SBIRT literature. Furthermore, this study promotes the learning
and understanding of how SBIRT might benefit patients with mild to moderate
methamphetamine use. The literature reviewed has focused on the effectiveness of BI as
part of the SBIRT model for reducing substance use, specifically methamphetamine use
disorder.
Conclusion
Substance use is common among patients in primary care settings. SBIRT has a
substantial health influence and is an effective approach that includes a coherent
framework to identify and manage substance use disorders and specific strategies to
promote behavior change. Brief validated screening tools allow rapid and efficient
identification of problematic drug use, including methamphetamine use disorder. After a
positive screening, a brief assessment is performed to stratify patients according to
severity: mild-moderate-severe use. Despite the lack of evidence that screening for
substance use disorders in general, and methamphetamine use disorder in particular,
improves outcomes, universal screening may be justified based on the high prevalence
and morbidity of substance use and proven effectiveness of treatment. In patients with
positive screening results, methamphetamine use should be stratified into mild-moderatesevere chronic relapsing use. Brief counseling is indicated for patients with mild to
moderate substance use disorder (SUD). Patients with a more severe subtype of SUD
require more intensive treatment beyond SBIRT and its BI.
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Substance use is characterized by the development of consequences from use, and
these consequences can serve as motivators for change. In primary care settings, medical
consequences from substance use can be instrumental in increasing motivation. Principles
and techniques derived from MI are used to manage ambivalence and increase readiness
to change. Developing a plan for change is an opportunity for the provider within a
primary care/hospital setting. Referral for specialty addiction treatment is recommended
for patients with severe chronically relapsing SUD. Access to specialty treatment is
variable, and decisions about where to refer patients must take into account local
resources and patient characteristics. Even in specialty addiction treatment, patients
benefit from close primary care coordination.
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Chapter 3: Research Method
The purpose of this quantitative study using an existing dataset was to test the
theory of intentional behavior change that relates to rehospitalizations. Rehospitalization
is based on the severity of methamphetamine abuse using the CAGE-AID score and
receiving a SBIRT in the Heart Failure Program at a Santa Clara County hospital.
In Chapter 3 of this study, I introduce the research question along with details
about the dependent and independent variables. In the chapter, I also define the target
population. I then explain the sampling and data collection for this study. I provide
operationalization for each variable and describe the threats to validity and address
ethical procedures. Chapters 4 and 5 consist of the data analysis and findings of the
research.
Research Question
The research question for this study was as follows: Does the SBIRT intervention
increase the patient’s ability to make a behavioral change and therefore make a difference
in rehospitalizations for patients with heart failure who screen positive for
methamphetamine use?
H01: There is no relationship between the dependent variable (rehospitalization)
when compared to the independent variables (SBIRT).
H11: There is a relationship between the dependent variable (rehospitalization)
when compared to the independent variables (SBIRT).
H01: There is no relationship between the dependent variable (rehospitalization)
when compared to the independent variables (CAGE-AID score).
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H11: There is a relationship between the dependent variable (rehospitalization)
when compared to the independent variables (CAGE-AID score).
Research Design and Rationale
This quantitative study used an existing dataset to test the theory of intentional
behavior change that relates to rehospitalizations based on the severity of
methamphetamine abuse (a) using the CAGE-AID score and (b) receiving a SBIRT in the
Heart Failure Program at a Santa Clara County hospital. The research design is a quasiexperimental, posttest only design with an observational comparison group. It was not
feasible to establish a randomized control group due to the nature of this community
intervention—it would not have been feasible to withhold SBIRT or substitute an
alternative intervention in a randomized control group in a community hospital.
Methodology
A Heart Failure (HF) Program at a Santa Clara Valley Medical Center (SCVMC)
was established in late 2011. The goal was to formulate a multidisciplinary approach to
improve the transition of care and to reduce readmissions for SCVMC HF patients.
Through collaboration with the Department of Alcohol and Drug Services (DADS), a
licensed clinical social worker (LCSW) was added to the HF program in October 2013.
The data presented in this report include a 52-week analysis.
Data were extracted from all hospitalized patients at SCVMC with a primary
discharge diagnosis of HF in the calendar year of 2013. In total, there were 608 patient
hospitalizations that received a primary diagnosis of HF. Because the addition of the
DADS LCSW to the HF Program, 375 total patients with both primary and nonprimary
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diagnoses of HF have been referred for SBIRT and if eligible, for an upgrade to
residential treatment. The inclusion criteria for the Heart Failure program were patients
with Heart Failure and LVEF ≤ 40%. A normal LVEF ranges from 55% to 70% (Tarango
& Baird, 2018). An LVEF of 65%, for example, means that 65% of the total amount of
blood in the left ventricle is pumped out with each heartbeat (Tarango & Baird, 2018).
The following exclusion criteria for the HF program study and this current study included
patients in Stage A or with diastolic dysfunction only due to other diseases that may
cause diastolic heart failure such as high blood pressure, diabetes, kidney disease,
coronary artery disease, or atrial fibrillation, a heart rhythm disorder. Other exclusions
included patients who are unable to care for self, have no reliable caregiver or residing in
a SNF; patients enrolled in palliative care/hospice; patients pending cardiac surgery; or
patients with end-stage renal disease.
Sampling Procedures
In logistic regression, the multivariate analysis proposed for this project, the
exponentiated beta, or odds ratio, is considered to be a reasonable effect size given a
dichotomous dependent variable. For this project, with a sample size of 375, an alpha of
.05, an anticipated multivariate model R2 of 0.1, and an anticipated odds ratio (effect size)
of 1.50 for the “group assignment” variable (SBIRT versus no SBIRT), the expected
power to find statistical significance is 0.96, as calculated using GPower 3.1 (Faul et al.,
2007). I used SPSS to analyze secondary data to understand the theory of intentional
behavior change that relates to rehospitalizations and the use of SBIRT and severity of
methamphetamine use (Hosmer et al., 2013). Three hundred and seventy-five patients
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were positive for methamphetamines from a total of 608. Of those 375 patients with heart
failure, 75 did not receive a BI.
Study Procedures
According to SAMHSA standards, the HF program used research based on a
comprehensive behavioral health SBIRT model to address the substance use in their
patients with heart failure, which reflected the six following characteristics:
1. It was brief. The initial screening was accomplished quickly (modal time
about 5–10 minutes) and the intervention and treatment components
indicated by the screening results were completed in significantly less time
than traditional substance abuse specialty care (SAMHSA, 2011).
2. The screening was universal. The patients were all screened as part of the
standard intake process (SAMHSA, 2011).
3. One or more specific behaviors were targeted. The screening tool
addressed a specific behavioral characteristic deemed to be problematic, or
pre-conditional to substance dependence or other diagnoses (SAMHSA,
2011).
4. The services occurred in a public health, or other nonsubstance abuse
treatment setting. This may be an emergency department, primary care
physician’s office, and school (SAMHSA, 2011).
5. It was comprehensive. The program included a seamless transition
between brief universal screening, BI and brief treatment, and referral to
specialty substance abuse care (SAMHSA, 2011).
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6. Strong research or substantial experiential evidence supported the model.
At a minimum, programmatic outcomes demonstrated a successful
approach (SAMHSA, 2011).
The HF Program’s SBIRT screening component consisted of the CAGE-AID
screening. There are many instruments available for screening and a brief assessment of
alcohol and drug problems. Their effectiveness varies according to their availability, ease
of administration, and test characteristics (Fiellin et al., 2000). Screening is a quick,
simple method of identifying patients who use substances at at-risk or risky levels and
who may already have substance use-related disorders (Bien et al., 1993). A screening
instrument provides specific information and feedback to the patient related to his or her
substance use. A common screening process involves the use of a brief one- to threequestion screen such as the CAGE-AID screen.
For this study, the screening tool used in the HF Program at Valley Medical
Center, which also serves as a pre- and post-test measure in the study, was the CAGEAdapted to Include Drug use (CAGE-AID). The CAGE-AID modifies the CAGE
questions for use in screening for drugs other than alcohol. CAGE represents the four
questions of the tool: cut down, annoyed, guilty, and eye-opener. The CAGE is a widely
used screening test for problem drinking and potential alcohol problems (Mayfield et al.,
1974). The CAGE questionnaire takes less than one minute to administer. The CAGE is
used in primary care or other general settings as a quick screening tool (Mayfield et al.,
1974). Example CAGE questions are as follows: (a) Have you ever felt you should cut
down on your drinking?; (b) Have people annoyed you by criticizing your drinking?; (c)
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Have you ever felt bad or guilty about your drinking?; and (d) Have you ever had a drink
first thing in the morning to steady your nerves or to get rid of a hangover (eye-opener)?
Like the CAGE, the CAGE-AID focuses on lifetime use (Mayfield et al., 1974).
In a study of its usefulness in a community family practice (Brown & Rounds, 1995), it
had a sensitivity to detect the extent of a drug or alcohol problem of 79% and a
specificity of 77%. The authors suggested that stigma associated with illicit drugs may
have limited its sensitivity. Stigma is a problem with any substance-use screening
instrument, but less so with the CAGE since it was designed to be less stigmatizing in
nature than other drug/alcohol use inventories. Limitations of the CAGE-AID are similar
to the CAGE in that it does not distinguish between active and inactive problems and has
not been validated for identifying hazardous or harmful use. The following are example
questions from the CAGE-Adapted to Include Drugs (CAGE-AID) (Mayfield et al.,
1974):
C: Have you ever thought you should Cut down on your drug use?
A: Have people Annoyed you by criticizing your drug use?
G: Have you ever felt bad or Guilty about your drug use?
E: Have you ever used drugs first thing in the morning to steady your nerves or
avoid withdrawal (Eye opener)?
This study reviewed patient electronic health records to view the scores of the
CAGE-AID screening. The CAGE-AID is a continuous independent variable based on
numerical value-interval 1–4. The CAGE-AID is a four-item survey about covert
problem drug use, adapted from the original CAGE alcohol questionnaire, which was
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found to be a reliable predictor of problem drinking (Mayfield et al., 1974). National
Institute on Alcohol Abuse and Alcoholism (NIAAA) has traditionally recommended that
the practitioner asks quantity and frequency questions followed by the CAGE screening
(Ewing, 1984). Each response is scored as 1. A score of 2 or higher is considered
clinically significant and should raise the clinician’s index of suspicion that the individual
has a SUD problem or disorder (Ewing, 1984).
CAGE-AID Screen Scoring (number of YES answers):
0–1: No risk. Reinforce healthy decisions.
1–2: Possible risky use: Advise. Patient education. Motivational conversation.
2–3: Risky Use: Motivational conversation, BI.
3–4: Possible dependence: Warm handoff to on-site behavioral health specialist
for assessment, brief treatment, possible referral to substance use treatment.
Due to language barriers, individual interpretation of the questions, or other
confounding factors, individuals answering “no” to all CAGE-AID questions may still be
at risk due to elevated drinking or drug use levels. The CAGE-AID has been validated as
four-item self-report and parent-report versions as a screen for substance use disorders
among adolescents in mental health care (Couwenbergh et al., 2009). The Heart Failure
Program’s SBIRT assessment component used the American Society of Addiction
Medicine (ASAM) Criteria. The HF program used the ASAM Criteria as their
multidimensional assessment as a guideline for treatment and referral to a higher level of
care. This assessment provides insight into how treatment might affect multiple life areas
of an individual. There are six dimensions, and each one influences the others. This

47
assessment is helpful in providing patients with more advanced treatment for possible
dependence, and if necessary, the patient is referred to a higher level of care.
The ASAM’s criteria resulted from a collaboration that began in the 1980s to
define one national set of criteria for providing outcome-oriented and results-based care
in the treatment of addiction (Mee-Lee, 2013). The ASAM criteria is the most widely
used and comprehensive set of guidelines for placement, continued stay, and
transfer/discharge of patients with addiction and co-occurring conditions (Mee-Lee,
2013). ASAM’s criteria are required in over 30 states. ASAM’s criteria is an
indispensable resource that addiction medicine professionals rely on to provide a
nomenclature for describing the continuum of addiction services (Mee-Lee, 2013).
The ASAM criteria are based on six dimensions:
Assessment Dimension 1: Acute Intoxication and Withdrawal Potential is the
assessment for intoxication and withdrawal management. Detoxification in a
variety of levels of care and preparation for continued addiction services.
Assessment Dimension 2: Biomedical Conditions and Complications is the
assessment and treatment of co-occurring physical health conditions or
complications. Treatment provided within the level of care or through
coordination of physical health services.
Assessment Dimension 3: Emotional, Behavioral, or Cognitive Conditions and
Complications is the assessment and treatment of co-occurring diagnostic or subdiagnostic mental health conditions or complications. Treatment provided within
the level of care or through coordination of mental health services.
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Assessment Dimension 4: Readiness to Change is the assessment of the stage of
readiness to change. If not ready to commit to full recovery, engage in treatment
using motivational enhancement strategies. If ready for recovery, consolidate, and
expand action for change.
Assessment Dimension 5: Relapse, Continued Use, or Continued Problem
Potential is the assessment of readiness for relapse prevention services.
Assessment Dimension 6: Recovery Environment is the assessment for the need
for specific individualized family or significant other, housing, financial,
vocational, educational, legal, transportation, childcare services.
Table 1 presents sample questions for each of the six dimensions (Mee-Lee,
2013):

49
Table 1
The Six Dimensions of Multidimensional Assessment From the ASAM by Mee-Lee (2013)
Dimension
1
2

•
•
•
•

3

•

4

•
•
•

5

•
•
•

6

•
•

Sample question
Are there current signs of withdrawal?
Has the patient been using multiple substances in the same
drug class?
Are there current physical illnesses other than withdrawal, that
need to be addressed or which complicate treatment?
Are there chronic conditions which might interfere with
treatment (e.g., chronic pain with narcotic analgesics)?
Do any emotional/behavioral problems appear to be an
expected part of addiction illness or do they appear to be
separate?
Is the patient suicidal, and if so, what is the lethality?
Does the patient feel coerced into treatment or actively object
to receiving treatment?
If willing to accept treatment, how strongly does the patient
disagree with others’ perception that s/he has an addiction
problem?
How aware is the patient of relapse triggers, ways to cope with
cravings, and skills to control impulses to use?
What is the patient’s level of current craving and how
successfully can they resist using?
Is the patient in immediate danger of continued severe distress
and drinking/drugging or other high-risk behavior due to cooccurring mental health problems?
Are there any dangerous family, significant others, living,
school, or working situations threatening treatment
engagement and success?
Are there barriers to access to treatment such as transportation
or childcare responsibilities?

The HF Program’s SBIRT BI component used the Brief Negotiated Interview
(BNI) as a guideline for their BI. BNI is a short counseling session that is completed
following the screening, and that incorporates brief feedback and advice with
motivational enhancement techniques to assist the patient in changing alcohol and drug-
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related behaviors. The BNI procedure is patient centered, and the skills used are based on
the patient’s motivation and readiness to change. The BNI used in this study was first
developed in 1994 by Edward Bernstein, Judith Bernstein and Gail D’Onofrio in
consultation with Project ASSERT in the emergency room (Bernstein et al., 1997).
Each step has critical components, specific objectives, and actions. The following
are the four steps of the BNI: (a) Raise the Subject Comfort; (b) Provide Feedback; (c)
Enhance Motivation; and (d) Negotiate and Advise. The primary outcome of the BNI
procedure is the patient’s agreement to reduce alcohol/drug amounts or accept a referral
to a formal specialized treatment center to decrease harm (medical problems or trauma)
(Bernstein et al., 1997). It was evident in the literature that BI for alcohol problems are
effective in a variety of settings including primary care and inpatient trauma settings
(D’Onofrio & Degutis, 2002; Fleming et al., 1997; Gentilello et al., 1999).
The brief negotiated interview was a dichotomous independent variable based on
the value if the patient received a BNI (Yes or No). This study reviewed patient
electronic health records to view if the patient received a BI.
The Brief Negotiated Interview (BNI) is a short counseling session that is done
following the screening, and that incorporates brief feedback and advice with
motivational enhancement techniques to assist the patient in changing alcohol and drugrelated behaviors (Bernstein et al., 1997). The BNI session is patient-centered, and the
skills used are based on the patient’s motivation and readiness to change (Bernstein et al.,
1997). This technique is important because this intervention is designed to motivate
patients to change their behavior and prevent the progression of substance use (Bernstein
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et al., 1997). BNI is a non-confrontational session that is designed to help improve
chances that the patient will reduce risky alcohol consumption or discontinue harmful
drug use (Bernstein et al., 1997). One interviewing technique is known as the FRAMES
model of intervention (Bernstein et al., 1997). This technique comprises:
• Giving Feedback regarding drug and alcohol use;
• Leaving Responsibility for change to the patient;
• Giving the Advice to make a change;
• Providing a Menu of options;
• Using an Empathic conversational style; and
• Boosting the patient’s Self-efficacy to make a change.
All patients who met the criteria for more advanced SUD treatment options, if
necessary, were referred to a higher level of care.
Data Collection Techniques
A Valley Medical Center HF Program provided the researcher with a deidentified data set according to specifications for sample and variables used in this study.
Santa Clara County has determined that using a completely de-identified data set meets
the federal criteria for not requiring IRB oversight of human subjects’ research. SCVMC
provided approval and support for this project and use of the dataset. The first variable
requested was the CAGE-AID score. The CAGE-AID is a continuous independent
variable based on numerical value-interval 1–4. The second variable that was requested
was the CAGE-AID received (CAGE-AID received = 1, no CAGE-ID received = 0). The

52
third variable was BI received (SBIRT = 1, no-SBIRT = 0), and the last variable is
Rehospitalizations within 30, 60, and 90 days (1 = Yes, 0 = No).
Each variable was entered into SPSS for 375 de-identified patients. SPSS was
used to analyze de-identified secondary data already collected by the HF team at SPSS
was used to analyze de-identified secondary data already collected by the HF team at
SCVMC to understand the theory of intentional behavior change that relates to
rehospitalizations and the use of SBIRT and severity of methamphetamine use (Hosmer
et al., 2013).
Dummy variables were created as a tool that allowed the researcher to represent
nominal-level independent variables in statistical techniques like regression analysis
(Laerd Statistics, n.d.). Each dummy variable was coded so that it has the value 1 if a
case is in that category, and 0 if not. Dummy variables are numerical variables used in
regression analysis to represent subgroups of the sample in a study (Laerd Statistics,
n.d.). For this study, gender and ethnicity were transformed into dummy variables whose
attributes were coded into dichotomous variables. A dummy variable is dichotomous,
e.g., the variable named “Hispanic” has only two attributes: 1 = Hispanic; 0 = Not
Hispanic.
Operationalization Variables Measured
The statistical logistic regression test allowed for this researcher to compare
which variables had the most influence comparing SBIRT or the severity of
methamphetamine use on rehospitalizations. One uses a dichotomous dependent variable
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when there are two or more independent variables of any type (SBIRT and CAGE-AID
score) (Hosmer et al., 2013).
The dependent variable was hospital-readmissions during the one-year study
period which included multiple inpatient stays within a specified period (30-60-90 days)
by the same patient (Hersh et al., 2013).
The two independent variables were SBIRT intervention (categorical) and CAGEAID score (continuous). SBIRT interventions: dichotomous independent variable based
on the value if the patient received SBIRT interventions (SBIRT = 1, no-SBIRT = 0)
which were conducted with each hospital admission. The CAGE-AID score is a
continuous independent variable based on numerical value-interval 1–4 which was
collected with each hospital admission.
The control and intervening variable is:
CAGE-AID: is a dichotomous variable based on the value if the patient received a
screening (CAGE-AID = 1, no-CAGE-AID = 0) upon each hospital admission.
Data Analysis Plan
I conducted three bi-variate dependent t-test comparing rehospitalizations for each
time frame by SBIRT and rehospitalizations by CAGE-AID.
For a categorical dependent variable when there are two or more independent
variables of any type (SBIRT and CAGE-AID score), logistic regression is an appropriate
multivariate procedure. This allowed for a comparison which independent variable had
more influence on the dependent variable. There were three separate regressions
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conducted for the dependent dichotomous variable for the 30, versus 60, versus 90-day
rehospitalizations.
The multivariate analysis strategy I utilized was the regression equation:
re-hosp = α + β1SBIRT + β2 CAGE-AID + µ
For this study, I sought to understand the links between rehospitalizations and the
influence of SBIRT and severity of methamphetamine use with patients who have
chronic health conditions specifically within patients with HF. I examined the secondary
data in depth to provide data interpretation for the results from the assumptions tests, the
results from the “Classification Table,” including sensitivity, specificity, positive
predictive value and negative predictive value; and the results from the “Variables in the
Equation” table, including which of the predictor variables were statistically significant
and what predictions were made based on the use of odds ratios.
Ethical Considerations
This study used a secondary data set, therefore posed no risk for any human
participants. Before any data was collected, I established approval from the International
Review Board (IRB). A letter of usage of agreement to use data was needed from the
hospital because patient information was not public record.
Limitations of the Study
Quantitative research main purpose is the quantification of the data (Simon,
2011). Since this study looked at a patient cohort with mild to moderate substance use
disorder (SUD), it was assumed they had greater motivation for change than those
patients with a severe chronic relapsing level of SUD severity. The current retrospective
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study had a scope and limitations that would restrict the research questions that were
answered. Social economic status, psychosocial issues, access to therapy, access to
healthcare, which all contributed to the higher incident of health risks were not within the
scope of this study. I was not looking at the severe chronic relapsing level of SUD
severity but mild to moderate SUD.
Furthermore, my sample did not consist of random sampling but rather a census
study because data was gathered on every member of the population. A threat to internal
validity was present due to the limited research design. It was not feasible to establish a
randomized control group due to the nature of this community intervention A randomized
control group was not feasible to withhold SBIRT or substitute an alternative intervention
in a randomized control group in a community hospital. The boundaries were set for this
study to facilitate interpretation of the results and help arrive at meaningful conclusions.
A limitation to this current study was that the threats to reliability may be
included the subjective responses to CAGE-AID and participants under reporting the
severity of their SUD. Another threat could have been that those patients who volunteer
for treatment might be considered to be more motivated to change than those patients
who did not participate in treatment and so the sample may have been biased.
Threats to theory validity may have occurred as well. At the beginning of an
investigation, the researcher usually has a specific viewpoint or theory that he or she feels
the data will support (Yardley, 2017). I ensured that I did not force the data to match a
particular theory, nor did I ignore data that does not suit the theory (Yardley, 2017).
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Summary of Research Design
The current quantitative study sought to illuminate the issue and the influence of
SBIRT with mild to moderate use of methamphetamine use and rehospitalization within
chronic patients with heart failure. This study contributed to social change as it might
open up discussions about the continued need for research on SBI and the effectiveness
with SUD. There is a need for a better understanding of the links between illicit drug use
and heart failure outcomes. There is a need for a better understanding of the influence of
direct interventions such as screening, assessments, and BI, on these patients’ outcomes
with chronic health conditions. Therefore, it is necessary to develop tailored interventions
in specialty clinics. For future researchers, there is a need to collaborate with National
Institute of Health, National Institute on Drug Abuse or Agency of Healthcare Research
and Quality to conduct more research on SBIRT approaches for substance use
interventions for patients with heart failure diagnoses.
While there is substantial research for the effectiveness of SBIRT in reducing
unhealthy alcohol use and tobacco use/misuse, the evidence for similar models in
addressing mild to moderate drug use and chronic health condition still needs to be
developed. This subject has been underwritten, and this study will promote social change
as for treatment providers to understand that SBIRT is a general approach and not a
specific technique. SBIRT needs to be modified for use in various settings and not a onesize fits all approach to address substance use (Zgierska et al., 2014).
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Chapter 4: Results
In Chapter 2, I identified important findings in relation to the challenges in the
effectiveness of the use of SBIRT for the treatment of mild to moderate
methamphetamine use disorder particularly with a patient cohort who have been
hospitalized for cardiac complications either caused by or exacerbated by continued
methamphetamine abuse (Saitz, 2014). The purpose of this quantitative study using an
existing dataset is to test the theory of intentional behavior change that relates to
rehospitalizations based on severity of methamphetamine abuse using the CAGE-AID
score and receiving a SBIRT in the HF Program at Santa Clara County Valley hospital.
In Chapter 4, I describe data collection, sample demographic characteristics, tests
of the assumptions, and results of the analysis with tables to demonstrate the data and
analysis. The demonstration of a statistically significant difference or lack of statistically
significant differences between these groups was determined with each B tested by the
Wald chi-square—testing the null that the B coefficient = 0 (the alternate hypothesis is
that it does not = 0). p values lower than alpha are significant, leading to the rejection of
the null. The analysis can be used to inform practice with the TTM process of intentional
behavioral change theory and can help a patient achieve goals of reduction or elimination
of substance use in the change process (Kennedy & Gregoire, 2009).
Data Collection
I extracted data from all hospitalized patients at a SCVMC HF Program with a
primary discharge diagnosis of HF in the calendar year of 2013. As described in Chapter
3, in total, there were 608 hospitalizations in the year 2013, which received a primary
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diagnosis of HF. These hospitalizations also comprised of patients with a LVEF ≤ 40%,
which were categorized into systolic HF. Patients were excluded if they were categorized
with diastolic dysfunctions only, unable to care for self, has no reliable caregiver, or
residing in a SNF. Patients were also excluded if enrolled in palliative care/hospice,
pending cardiac surgery, or end-stage renal disease. This study focused on the 375
patients who screened positive from a urine toxicology screen for substances from the
total of 608 patients with HF in the year 2013. This sample did not consist of random
sampling but rather a census study because data was gathered on every member of this
population. Exclusion criteria are patients who did not test positive for substance use and
were not referred for SBIRT.
Sample Demographic Characteristics
I analyzed clinical data, which I collected from the HF Program participants at
SCVMC. I deidentified the data in accordance with the Substance Use Treatment
Services Department. As the data are not identifiable, there was no way to follow up with
the participants. To deidentify the data, I removed all names and identifying information
associated with the data. There is no key to reidentify the data or link it to any identifying
information.
Table 2 shows the frequency count and percent of total count of male and female.
There were a total of 375 participants included in this study: 100 females (26.7%) and
275 males (73.3%). The largest ethnicity was Caucasian at 132 participants (35.2%),
followed by Asian at 112 (29.9%), Hispanic at 109 (29.1%), and African American at 22
(5.9%). There was a total of 64 participants who did not receive a CAGE-AID (17.1%)
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and 311 received a CAGE-AID (82.9%). There were a total of 375 CAGE-AID scores
included in this study; the highest score is two with a total of 115 (30.7%). The mean
CAGE-AID score is 1.82 and the standard deviation is 1.20. There was a total of 74
participants who did not receive an SBIRT (19.7%) and 301 participants received an
SBIRT (80.3%).
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Table 2
Frequency: Gender, Ethnicity, CAGE-AID, CAGE-AID Score, and Brief Intervention
Frequency

Percentage of total

Female
Male

100
275

26.7%
73.3%

Total

375

100%

Hispanic
Caucasian
Asian
African Am
Total
CAGE-AID
Screening
Does not have
CAGE-AID
Has CAGE-AID
Total
CAGE-AID Score
0
1
2
3
4
Total

109
132
112
22
375

29.1%
35.2%
29.9%
5.9%
100%

64

17.1%

311
375

82.9%
100

66
80
115
82
32
375

17.6%
21.3%
30.7%
21.9%
8.5%
100%

Gender

Ethnicity

Table 3 shows the frequency count and percentage of total for patients
rehospitalized/not hospitalized within 30 days. There were a total of 375 participants
included in this study; 185 participants did not experience a 30-day rehospitalization
(49.3%) and 190 participants experienced a 30-day rehospitalization (50.7%). There was
a total of 209 who participants did not experience a 60-day rehospitalization (55.7%) and
166 participants who experienced a 60-day rehospitalization (44.7%). There was a total
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of 203 participants who did not experience a 90-day rehospitalization (54.1%) and 171
participants who experienced a 90-day rehospitalization (45.6%).
Table 3
Frequency: 30-Day Rehospitalization, 60-Day Rehospitalization, and 90-Day
Rehospitalization
30-Day
Rehospitalized
Did not get
Rehospitalized
Did get
Rehospitalized
Total
60-Day
Rehospitalized
Did not get
Rehospitalized
Did get
Rehospitalized
Total
90-Day
R-hospitalized
Did not get
Rehospitalized
Did get
Rehospitalized
Total

Frequency

Percentage total

185

49.3%

190

50.7%

375

100%

209

55.7%

166

44.3%

375

100%

203

54.4%

171

45.6%

375

100%
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Table 4 shows the comparison of the two groups on key variables.
Table 4
Comparison of SBIRT and non-SBIRT Groups on Characteristics
Frequency
(percentage of
total) SBIRT
total (301)

Frequency
(Percentage of
total) nonSBIRT
total (74)

Chi-square

p value

24.6%
75.4%

35.1%
64.9%

3.381

.066

29.6%
34.2%
31.2%
5%

27%
39.2%
24.3%
9.5%

3.525

.317

0.3%

85.1%

301.794

.000

99.7%

14.9%

56.8%

18.9%

34.119

.000

43.2%

81.1%

58%

45.9%

3.580

.058

41.9%

54.1%

57.3%

41.9%
5.703

.017

42.7%

58.1%

Gender
Female
Male
Ethnicity
Hispanic
Caucasian
Asian
African Am
CAGE-AID
Screening
Does not have
CAGE-AID
Has CAGE-AID
30-Day
Rehospitalized
Did not get
Rehospitalized
Did get
Rehospitalized
60-Day
Rehospitalized
Did not get
Rehospitalized
Did get
Rehospitalized
90-Day
Rehospitalized
Did not get
Rehospitalized
Did get
Rehospitalized
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Sample
Researcher requested a Valley Medical Center HF Program provide the researcher
with a deidentified data set according to specifications for sample size of 375 Patients
with heart failure who were referred for SBIRT and screen positive for substance use.
Variables requested were CAGE-AID score, CAGE-AID received, BI received,
rehospitalized within 30, 60, and 90 days.
The sample did not consist of random sampling but rather a census study because
data was gathered on every member of the population. A threat to internal validity is
present due to the limited research design. It was not feasible to establish a randomized
control group due to the nature of this community intervention. A randomized control
group would not have been feasible to withhold SBIRT or substitute an alternative
intervention in a randomized control group in a community hospital.
Results
Process
SCVMC provided approval and support for this project and use of the dataset.
The first variable requested was the CAGE-AID score. The CAGE-AID is a continuous
independent variable based on numerical value-interval 1–4. The second variable that
was requested was the CAGE-AID received (CAGE-AID received = 1, no CAGE-ID
received = 0). The third variable was BI received (SBIRT = 1, no-SBIRT = 0), and the
last variable is Rehospitalizations within 30, 60, and 90 days (1 = Yes, 0 = No). Each
variable was entered into SPSS for 375 de-identified patients. SPSS was used to analyze
de-identified secondary data already collected by the HF team at SCVMC.
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I created dummy variables as a tool that allowed me to represent nominal-level
independent variables in statistical techniques like regression analysis (Laerd Statistics,
n.d.). I coded each dummy variable so that it has the value 1 if a case is in that category,
and 0 if not.
Assumptions
To conduct a logistic regression test, the following assumptions need to be held.
The first assumption is that the dependent variable is binary. The dependent variable
(rehospitalization Yes/No) for this study is dichotomous and therefore satisfies this
assumption. The second assumption requires the observations to be independent of each
other. This assumption is satisfied because data does not come from matched data or
repeated measures. The third assumption that needs to be satisfied is that there must be
little to no multicollinearity in the data. The test for multicollinearity is discussed below.
This assumption is satisfied because the independent variables are independent from each
other. The fourth assumption assumes linearity of independent variables, and this
assumption is true because the independent variables are linearly related to the log odds.
Finally, logistic regression requires a large sample size. This assumption is satisfied
because this sample size is large enough. For this project, with a sample size of 375, an
alpha of .05, an anticipated multi-variate model R2 of 0.1, and an anticipated odds ratio
(effect size) of 1.50 for the “group assignment” variable (SBIRT versus no SBIRT), the
expected power to find statistical significance is 0.96, as calculated using GPower 3.1
(Faul et al., 2007).
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Statistical Analysis
One research question was addressed with the statistical logistic regression test.
The statistical logistic regression test compared which variables had the most influence
comparing SBIRT (BI) or the severity of methamphetamine use on rehospitalizations.
Logistic regression was most suitable for a dichotomous dependent variable, when there
are two or more independent variables of any type (SBIRT and CAGE-AID score)
(Hosmer et al., 2013).
The dependent variable is hospital-readmissions during the one-year study period.
Multiple inpatient stays within a specified period (30, 60, and 90 days) by the same
patient (Hersh et al., 2013).
The two independent variables are SBIRT intervention (categorical) and CAGEAID score (continuous). SBIRT interventions: dichotomous independent variable based
on the value if the patient received SBIRT interventions (SBIRT = 1, no-SBIRT = 0)
which were conducted with each hospital admission. The CAGE-AID score is a
continuous independent variable, based on numerical value-interval 1–4, which was
collected with each hospital admission.
The control and intervening variables are:
CAGE-AID: is a dichotomous variable based on the value if the patient received a
screening (CAGE-AID = 1, no-CAGE-AID = 0) upon each hospital admission.
To begin the test, I formulated the null and alternate hypothesis. The following
are the null and alternate hypotheses:
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H01: There is no relationship between the dependent variable (rehospitalization)
when compared to the independent variables. (SBIRT)
H11: There is a relationship between the dependent variable (rehospitalization)
when compared to the independent variables. (SBIRT)
H01: There is no relationship between the dependent variable (rehospitalization)
when compared to the independent variables. (CAGE-AID Score)
H11: There is a relationship between the dependent variable (rehospitalization)
when compared to the independent variables. (CAGE-AID Score)
The Hosmer and Lemeshow Test was used to determine if the model is sufficient
by testing the Null hypothesis that the probability of rehospitalization is no different than
that predicted by the models. Three bi-variate dependent t-test were conducted to
compare rehospitalizations for each time frame (30, 60, and 90 days) by SBIRT and
rehospitalizations (30, 60, and 90 days) by CAGE-AID was completed. The Variance
Inflation Factor (VIF) is a measure of multicollinearity, or correlation
between independent variables. The VIF diagnostic test is available in SPSS for linear
regression, but not logistic regression. In order to assess this with SPSS, the logistic
regression model was run as a linear regression, only specifying the output for
collinearity diagnostics. This was done iteratively, substituting each independent variable
as the dependent variable. A VIF score above five is considered to be high collinearity
(Montgomery et al., 2014). There were no VIF scores higher than 1.30 in any of these
diagnostic tests. Finally, which included three separate regressions for the dependent
dichotomous variable for the 30 versus 60 versus 90-day rehospitalizations.
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30-day Hospitalizations
Research Question 1 asked: Does the SBIRT intervention increase the patient’s
ability to make a behavioral change and therefore make a difference in rehospitalizations
for patients with heart failure who screen positive for methamphetamine use?
In Table 5 from the output crosstabulation, it is demonstrated that there is 19.7%
of heart failure clients that did not receive SBIRT while 80% received SBIRT equally
accumulative of 100% for both. I then conducted the Chi-Square to determine if there is a
relationship between these two variables; this test is statistically significant (X2 = 34.12, p
< .001). Based on the Chi-Square test, the null hypothesis can be rejected, meaning there
is a relationship between 30-day rehospitalizations and receiving SBIRT.
Table 5
30-Day Rehospitalization and SBIRT Crosstabulation
No
Received
SBIRT SBIRT
(N, %) (N, %)
14
18.9%

171
56.8%

Rehospitalized

60
81.1%

130
43.2%

Total

74
100%
41

301
100%

Did not get Rehospitalized
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The steps were repeated to test the second Null Hypothesis.
H01: There is no relationship between the dependent variable (rehospitalization)
when compared to the independent variables (CAGE-AID Score). There are 375 valid
cases in this study. In Table 6 from the output crosstabulation, I demonstrated that 17.1%
of HF clients did not receive a CAGE-AID screen while 82.9 % received CAGE-AID
screening equally accumulative of 100% for both. I then conducted the Chi-Square to
determine if there is a relationship between these two variables; this test is statistically
significant (X2 = 28.89, p < .001). Based on the Chi-Square test, the null hypothesis can
be rejected, meaning there is a relationship between 30-day rehospitalizations and
receiving CAGE-AID screen.
Table 6
30-Day Rehospitalization and CAGE-AID Screen Crosstabulation
No
CAGEAID
(N, %)

Received
CAGEAID
(N, %)

12
6.5%

173
93.5%

Rehospitalized

52
27.4%

138
72.6%

Total

64
100%

311
100%

Did not get Rehospitalized

Once a statistically significant difference was determined with the Chi-Square
tests for the dependent variable of rehospitalization and SBIRT and rehospitalization by
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CAGE-AID, the multivariate analysis logistic regression was utilized. Table 7 shows the
independent variable coefficients and related statistics. Even though it was statistically
significant, the odds ratio impact for BI is low (Exp (B) = .039, p = .002), however, the
influence of CAGE-AID Score has a five-fold increase in the likelihood of being
rehospitalized within 30 days (Exp (B) = 5.144, p = .000).
Table 7
Influence of Independent Variables on 30-day Rehospitalization with sample size 375
B
Brief Intervention
-3.237
CAGE-AID Score
1.638
Female
-.269
Hispanic*
-.405
Asian or not*
-.089
African American* -.903
Age
-.010
Constant
-.003
*Caucasian is the baseline category

S.E.
1.060
.195
.325
.362
.350
.738
.013
1.209

Exp (B)
.039
5.144
.764
.667
.915
.406
.990
.997

P Value
.002
.000
.408
.263
.799
.221
.455
.998

60-day Hospitalizations
Research Question 1 asked: Does the SBIRT intervention increase the patient’s
ability to make a behavioral change and therefore make a difference in rehospitalizations
for patients with heart failure who screen positive for methamphetamine use?
In Table 8 from the output crosstabulation, it is demonstrated that there is 19.7%
of HF clients that did not receive SBIRT while 80.3% received SBIRT equally
accumulative of 100% for both. I then conducted the Chi-Square to determine if there is a
relationship between these two variables; this test is not statistically significant (X2 =
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3.58, p < .058). Based on the Chi-Square test, the null hypothesis can be accepted,
meaning there is no relationship between 60-day rehospitalizations and receiving SBIRT.
Table 8
60-Day Rehospitalization and SBIRT Crosstabulation
No
Received
SBIRT SBIRT
(N, %) (N, %)
34
16.3%

175
83.7%

Rehospitalized

40
24.1%

126
75.9%

Total

74
100%

301
100%

Did not get Rehospitalized

The steps were repeated to test the second Null Hypothesis.
H01: There is no relationship between the dependent variable (rehospitalization)
when compared to the independent variables (CAGE-AID Score). In Table 9 from the
output crosstabulation, I demonstrated that 13.9% of HF clients did not receive a CAGEAID screen while 86.1 % received CAGE-AID screening equally accumulative of 100%
for both. I then conducted the Chi-Square to determine if there is a relationship between
these two variables; this test is not statistically significant (X2 = 3.40, p < .065). Based on
the Chi-Square test, the null hypothesis can be accepted, meaning there is a no
relationship between 60-day rehospitalizations and receiving CAGE-AID screen.
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Table 9
60-Day Rehospitalization and CAGE-AID Screen Crosstabulation
No CAGEAID
(N, %)

Received
CAGE-AID
(N, %)

Did not get
Rehospitalized

29
13.9%

180
86.1%

Rehospitalized

35
21.1%

131
78.9%

Total

64
100%

311
100%

Once a statistically significant difference was not determined with the Chi-Square
tests for the dependent variable of rehospitalization and SBIRT and rehospitalization by
CAGE-AID, the multivariate analysis logistic regression was still utilized. Table 10
shows the independent variable coefficients and related statistics. Although the influence
of having a BI is not statistically significant (Exp (B) = .497, p = .277), controlling for all
other variables, there is still an influence of the CAGE-AID score on 60-day
rehospitalizations.
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Table 10
Influence of Independent Variables on 60-day Rehospitalization with sample size 375
B
Brief Intervention
-.698
CAGE-AID Score
.363
Female
-.119
Hispanic*
-.006
Asian*
-.158
African American* -.335
Age
-.024
Constant
-1.576
*Caucasian is the baseline category

S.E.
.643
.125
.273
.295
.292
.547
.011
.886

Exp (B)
0.497
1.438
.888
1.006
.854
1.398
1.024
.207

P Value
.277
.004
.664
.983
.590
.540
.030
.075

90-day Hospitalizations
Research Question 1 asked: Does the SBIRT intervention increase the patient’s
ability to make a behavioral change and therefore make a difference in rehospitalizations
for patients with heart failure who screen positive for methamphetamine use?
From the output crosstabulation in Table 11, it is demonstrated that 19.8% of HF
clients did not receive SBIRT while 80.2% received SBIRT equally accumulative of
100% for both. I then conducted the Chi-Square to determine if there is a relationship
between these two variables; this test is statistically significant (X2 = 5.70, p < .017).
Based on the Chi-Square test, the null hypothesis can be rejected, meaning there is a
relationship between 90-day rehospitalizations and receiving SBIRT.
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Table 11
90-Day Rehospitalization and SBIRT Crosstabulation
No
Received
SBIRT SBIRT
(N, %) (N, %)
Did not get
Rehospitalized

31
15.3%

172
84.7%

Rehospitalized

43
25.1%

129
74.9%

Total

74
100%

301
100%

The steps were repeated to test the second Null Hypothesis.
H01: There is no relationship between the dependent variable (rehospitalization)
when compared to the independent variables (CAGE-AID Score). There are 375 valid
cases in this study. In Table 12 from the output crosstabulation, I demonstrated that
17.1% of HF clients did not receive a CAGE-AID screen while 82.9% received CAGEAID screening equally accumulative of 100% for both. I then conducted the Chi-Square
to determine a relationship between these two variables; this test is not statistically
significant (X2 = 2.50, p < .114). Based on the Chi-Square test, I can accept the null
hypothesis, meaning there is no relationship between 90-day rehospitalizations and
receiving CAGE-AID screen.
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Table 12
90-Day Rehospitalization and CAGE-AID Screen Crosstabulation
No
CAGEAID
(N, %)

Received
CAGEAID
(N, %)

29
13.9%

174
86.1%

Rehospitalized

36
21.1%

136
78.9%

Total

65
100%

310
100%

Did not get Rehospitalized

Once a statistically significant relationship was determined with the Chi-Square
tests for the dependent variable of rehospitalization and SBIRT and not determined for
rehospitalization by CAGE-AID, the multivariate analysis logistic regression was still
utilized. Table 13 shows the independent variable coefficients and related statistics. There
is statistically significant influence for BI (Exp (B) = .218, p = .034); the influence for
those who do not receive an SBIRT have a 22% higher chance of hospitalization within
90 days. The CAGE-AID score also continues to have an influence in 90-day
rehospitalizations.
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Table 13
Influence of Independent Variables on 90-day Rehospitalization with sample size 375
B
Brief Intervention
-1.523
CAGE-AID Score
.380
Female
.057
Hispanic*
.017
Asian*
.085
African American* .052
Age
.031
Constant
-1.213
*Caucasian is the baseline category

S.E.
.717
.127
.275
.299
.293
.559
.011
.930

Exp (B)
.218
1.462
1.059
1.017
1.088
1.053
1.031
.297

P Value
.034
.003
.836
.955
.772
.926
.005
.192

Summary of Results
This was a quantitative, quasi-experimental, post-test only design with an
observational comparison group study. The sample included the use of an existing
dataset. Bivariate and multivariate analyses were conducted to test hypotheses about the
influence of SBIRT and the severity of methamphetamine use on rehospitalizations over
30-, 60-, and 90-day periods.
Table 14
Summary of Multi-Variate Findings
Rehospitalization
30-day
60-day
90-day

SBIRT
Statistically significant,
but low influence
Not statistically
significant
Statistically significant
and moderate influence

CAGE-AID Score
Statistically significant and high
influence
Statistically significant and high
influence
Statistically significant and high
influence
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The statistical logistic regression test compared which variables had the most
influence comparing SBIRT or the severity of methamphetamine use on
rehospitalizations. The CAGE-AID Score was statistically significant with 30-, 60-, and
90-day rehospitalization while controlling for all other variables. In Chapter 5, I discuss
interpretations of the findings, limitations of the study, recommendations going forward,
and implications for social change.
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Chapter 5: Discussion, Conclusion, and Recommendations
The purpose of this quantitative study using an existing dataset is to test the
theory of intentional behavior change that relates to rehospitalizations. In my analysis for
this study, I have showed that there were statistically significant relationships between
SBIRT on 30 and 90 days, but it was a small effect and no effect at all on 60 days. The
CAGE score had a significant and sizeable effect in all 30, 60, and 90 days analyses.
Chapter 5 includes an interpretation of the findings, discussion of the theoretical
framework and the findings, limitations, recommendations going forward, and
implications for social change.
Interpretation of Findings
Research Questions
The research question for the study is restated in this section with the significance
levels for each hypothesis: Does the SBIRT intervention increase the patient’s ability to
make a behavioral change and therefore make a difference in rehospitalizations for
patients with heart failure who screen positive for methamphetamine use?
Based upon chi-square tests, the data suggested that the test is significant at the
0.01 level and well below the common 0.005 threshold. Based on the Chi-square test, I
can rejected the null hypothesis, meaning that there is a relationship between 30-day
rehospitalizations and receiving SBIRT and CAGE-AID screen. Multivariate logistic
regression confirmed the Chi-square test. Controlling for gender, ethnicity, and age for a
30-day rehospitalization had a statistically significant effect for having a BI (Exp (B) =

78
.039, p = .002), the influence of CAGE-AID Score has a five-fold increase in the
likelihood of being rehospitalized (Exp (B) = 5.144, p = .000).
At 60-day rehospitalization days the statistically significance effect for having a
BI is low (Exp (B) = .497, p = .277), controlling for all other variables, there is still an ss
of the CAGE-AID score on 60-day rehospitalizations.
At the 90-day rehospitalization there is statistically significant effect for having a
BI (Exp (B) = .218, p = .034), the effect for those who do not receive an SBIRT have a
22% higher chance of hospitalization within 90 days. Controlling for all other variables,
there is still an effect of SBIRT and CAGE-AID score on 90-day rehospitalizations.
The findings from the multivariate logistic regression confirmed the chi-square
test. Controlling for age, ethnicity, and gender, rehospitalization was more than five times
more likely to occur based on the influence of CAGE-AID score. The data presented in
this study suggest that there was a link between 30-day rehospitalizations and the effect
of severity of methamphetamine use with patients who have chronic health conditions,
particularly those who have heart conditions. Based on this study’s findings and what has
been found in the literature (Chapter 2), this study is important because it contributes to
the field of physical and behavioral health and promotes an understanding of the
influence of SBIRT with mild and moderate methamphetamine use disorders and
comorbid medical conditions. These findings should, however, be examined in light of
the study’s important limitations.
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Theoretical Framework and Findings
During the literature review, the theoretical base for this study was the TTM. The
TTM began in the 1970s as an attempt to delineate an overarching behavior change
process (Migneault et al., 2005). The TTM has progressed to view change as occurring
over time (Prochaska et al., 1992). The TTM provides suggested strategies such as
SBIRT for public health interventions to address intentional behavior change.
In the literature review, several studies found that readiness to change was an
important predictor of response to substance use interventions. More specifically,
participants who reported greater recognition that their substance use was problematic
and of the need for change reported larger reductions in their postintervention substance
use involvement (Bertholet et al., 2009; Carpenter et al., 2002; Collins et al., 2012). The
review of these studies suggests that people are more inclined to changing their substance
use if they are aware that a problem exists and recognize the need for change (Bertholet
et al., 2009; Carpenter et al., 2002; Collins et al., 2012).
Methamphetamine use is associated with higher rates of a chronic medical
condition (NIDA, 2013; Stanford, 2009; Yeo et al., 2007). Substance use plays a role in
the development and exacerbation of chronic medical conditions such as heart failure.
Therefore, it is important for health care practitioners to detect and address substance use
in populations with chronic health conditions such as heart failure. After concluding the
data collection and reviewing the results, it was demonstrated that there is a relationship
between 30-day rehospitalizations and receiving SBIRT and CAGE-AID screen. The 30day rehospitalization had a statistically significant effect for receiving a BI. Knowing the
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severity of methamphetamine use based on the CAGE-AID Score has a five-fold increase
in the likelihood of being rehospitalized.
When providers do not screen or assess for substance use and misuse, this can
compromise medical treatment in numerous ways. As the literature found, substance use
and misuse increase the risks for adverse drug interactions and hampers adherence to
medications and other treatment protocols (Paratz et al., 2016). Some people do not know
that their level of substance use is risky. Studies have demonstrated education and
feedback about the level of use may be enough to motivate change (Tarango & Baird,
2018). Although the influenc for having a BI was low while controlling for all other
variables, the findings revealed there was still an influence for patients to be screened
using the CAGE-AID and CAGE-AID score on 60-day rehospitalizations.
There has been a significant amount of research that has identified the efficacy of
the use of screening, BI and referral to treatment (SBIRT) for reducing problem alcohol
use (SAMSHA, n.d.). Multiple trials of research relating to SBIRT provide evidence of
SBIRT's effectiveness (Bertholet et al., 2009; Moyer et al., 2002; Whitlock et al., 2004).
Over the past 5 years, however, a handful of research studies demonstrate the
effectiveness for reducing illicit drug use among non-treatment-seeking patients (Saitz,
2014). This study examined the links between the use of screening and use of SBIRT for
the treatment of mild to moderate methamphetamine use disorder particularly with a
patient cohort who have been hospitalized for cardiac complications either caused by or
exacerbated by continued methamphetamine abuse.
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The research expanded to explore the use of SBIRT for its suitable method of
identification and intervention techniques for evidence of efficacy in reducing illicit
substance use (Dwinnells, 2015). Dwinnells’s (2015) quasi-experimental study examined
the effectiveness of the SBIRT at a community health center. The results suggest that in
an outpatient clinic, SBIRT is effective in identifying patients at risk for depression,
alcohol, and substance use. The BI part of SBIRT is a strategy by which people gain
skills and confidence to help people understand and move through intentional behavioral
change (DiClemente, 2018).
The BI that was used in the Heart Failure study, Brief Negotiated Interview, used
motivational enhancement and cognitive behavioral approaches to help their patients
address unhealthy thoughts and behaviors associated with current use patterns and
acquire change. This BI encompasses the many concepts of intentional behavior change
theory. This study demonstrated at the 90-day rehospitalization there is a statistically
significant influence for those that did not receive an SBIRT had a 22 percent higher
chance of hospitalization within 90 days.
This study demonstrated that an SBIRT intervention increases the
methamphetamine using patients with heart failure’ ability to make a behavioral change
and therefore make a difference in rehospitalizations. Despite research indicating low
efficacy of BI for drug use found through screening in the primary care setting, the results
showed that participants who received BI had less rehospitalizations over time.
Finally, as applied to this study, the TTM process of intentional behavioral change
theory held true by the independent variables, which were the severity of
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methamphetamine use and receiving SBIRT. These independent variables influenced the
dependent variable which is the rehospitalizations. The intentional behavior change can
help a patient achieve goals of reduction or elimination of compulsive and continued
substance use in the change process (Kennedy & Gregoire, 2009). TTM was applied to
the cohort of patients with heart failure who received SBIRT versus those that did not.
As for the theory of behavior change, using the CAGE score is a proxy for state of
change since it was not measured directly. In general, the higher the CAGE score
indicates the lower the readiness to change, the more likely to be rehospitalized,
underscoring the importance of continuing to use the CAGE or similar screening in HF
patients. Behavior change is indicated by controlling for CAGE-AID, SBIRT has some
influence on 30- and 90-day rehospitalization rates. According to the analysis, the CAGE
score is predictive of rehospitalization; but despite that SBIRT still has an influence,
though not quite as influential as the CAGE score. The CAGE score odds are higher than
that of SBIRT. Every point higher in the CAGE score increases the rate of hospitalization
within 90 days by 46%, whereas having SBIRT avoids rehospitalization by 22%.
Limitations
This study looked at a patient cohort with mild to moderate substance use disorder
(SUD). It was assumed they had greater motivation for change than those patients with a
severe chronic relapsing level of SUD severity. The current retrospective study had scope
and limitations that restricted the research questions that were answered. Socioeconomic
status, psychosocial issues, access to therapy, access to healthcare, which all contribute to
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the higher incidence of health risks, were not within the scope of this study. I did not look
at the severe chronic relapsing level of SUD severity, but mild to moderate SUD.
Furthermore, my sample from the Santa Clara County hospital may not be
representative of other geographic regions. The limited research design left the study
open to several threats to internal validity. It was not feasible to establish a randomized
control group due to the nature of this community intervention; a randomized control
group was not feasible to withhold SBIRT or substitute an alternative intervention in a
randomized control group in a community hospital. The boundaries were set for this
study to facilitate interpretation of the results and helped to arrive at meaningful
conclusions.
A limitation to this current study was that the threats to reliability included the
subjective responses to CAGE-AID and participants under reporting the severity of their
SUD. Despite the utility of the CAGE-AID in determining valid responses, there was still
the possibility of inaccurate self-response. Another threat could have been that those
patients who volunteered for treatment might be considered to be more motivated to
change than those patients who did not participate in treatment, and so the sample may
have been biased. These results, though promising, need further follow-up with a larger
sample size over time.
Recommendations
While there is substantial research for the effectiveness of SBIRT in reducing
unhealthy alcohol use and tobacco use/misuse, there are few research studies that
demonstrate the effectiveness for reducing illicit drug use among non-treatment-seeking
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patients (Saitz, 2014). However, this study provides statistical significance in the use of
SBIRT for the treatment of mild to moderate methamphetamine use disorder, particularly
with a patient cohort who have been hospitalized for cardiac complications either caused
by or exacerbated by continued methamphetamine abuse.
Within the limits of this study, other chronic health conditions treated in primary
care warrant an exploration for the effectiveness of SBIRT. As such, a recommendation
to invest in developing a similar study exploring SBIRT-like models for most common
behavioral health conditions, such as smoking and asthma and alcohol and hypertension,
for use in public health settings. This would involve research of these comorbidities and
conducting a comparative study design utilized in this research.
Implications for Social Change
Despite this study’s limitations, the influence of CAGE-AID Score having a large
]]difference with a five-fold increase in the likelihood of being rehospitalized in 30 days
compared to 60 and 90-day hospitalizations calls for additional research. If under more
rigorous conditions, the findings can be replicated, then the field of physical and
behavioral health will have a new and significant evidence-based strategy to support
substance-using patients with heart failure to recover. This study is unique because it
addressed an under-researched area for individuals with mild and moderate substance use
problems with comorbid medical conditions.
The potential for positive social change is for treatment providers to understand
that SBIRT is a general approach and not a specific technique. I must modify SBIRT for
use in various settings. A one-size-fits-all approach to address substance use does not
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work (Zgierska et al., 2014). The results of this study help health care providers such as
doctors, nurses, and health educators and social workers to assist in patient substance use
recovery and coordinate patient discharge and continuity of care following discharge to
influence the decrease in rehospitalizations (NASW, 2014).
The potential significance of this research is that it contributed to the existing
body of SBIRT literature by helping to understand how SBIRT might benefit patients
with mild to moderate methamphetamine use. It is essential to note that the efficacy of
SBIRT in reducing or eliminating methamphetamine use has not been investigated and
addressed with patients with HF.
Conclusion
Methamphetamine is one of the most cardiotoxic drugs and can cause numerous
heart failure problems stemming from chronic drug-induced hypertension, tachycardia,
and cardiac arrhythmia (Yeo et al., 2007). A diagnostic feature of methamphetamine use
disorder is continued compulsive use despite adverse medical consequences (DSM-5).
Even though methamphetamine-associated problems are recognized, there is rarely any
intervention to reduce methamphetamine use and further complications (Zgierska et al.,
2014). This study has demonstrated that screening and BI—at least for the mild to
moderate methamphetamine use conditions—results in a statistically significant
reduction/elimination of continued use and subsequently a reduction in rehospitalizations.
Despite some limitations, these findings enhance our understanding of the relationship
between SBIRT and the severity of methamphetamine use on rehospitalizations at 30, 60
and 90 days.

86
References
Amaral, M., Ronzani, T., & Souza-Formigoni, M. (2010). Process evaluation of the
implantation of a screening and brief intervention program for alcohol risk in
primary health care. Drug and Alcohol Review, 29(2), 162–168.
doi:10.1111/j1465-3362.2009.00120 x
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental
disorders (5th ed.). Washington, D.C.: Author.
Babor, T. F., McRee, B. G., Kassebaum, P. A., Grimaldi, P. L., Ahmed, K., & Bray, J.
(2007). Screening, brief intervention, and referral to treatment (SBIRT): Toward a
public health approach to the management of substance abuse. Substance Abuse,
28(3), 1233–1253. doi:10.1300/J465v28n03_03
Beich, A., Thorsen, T., & Rollnick, S. (2003). Screening in brief intervention trials
targeting excessive drinkers in general practice: Systematic review and metaanalysis. British Medical Journal, 327(7414), 536–542.
doi:10.1136/bmj.327.7414.536
Bernstein, E., Bernstein, J., & Levenson, S. (1997). Project ASSERT: An ED-based
intervention to increase access to primary care, preventive services, and the
substance abuse treatment system. Annals of Emergency Medicine, 30(2), 181–
189. doi:10.1016/s0196-0644(97)70140-9
Bernstein, J., Bernstein, E., Tassiopoulos, K., Heeren, T., Levenson, S., & Hingson, R.
(2005). Brief motivational intervention at a clinic visit reduces cocaine and heroin
use. Drug Alcohol Dependence, 77(1), 49–59.

87
doi:10.1016/j.drugalcdep.2004.07.006
Bertholet, N., Cheng, D. M., Palfai, T. P., Samet, J. H., & Saitz, R. (2009). Does
readiness to change predict subsequent alcohol consumption in medical inpatients
with unhealthy alcohol use. Addictive Behaviors, 34(8), 636–640.
doi:10.1016/j.addbeh.2009.03.034
Bien, T. H., Miller, W. R., & Tonigan, J. S. (1993). Brief intervention for alcohol
problems: A review. Addiction, 88(3), 315–335. doi:10.1111/j.13600443.1993.tb00820.x
Brown, R., & Rounds, L. (1995). Conjoint screening questionnaires for alcohol and other
drug abuse: Criterion validity in a primary care practice. Wisconsin Medical
Journal, 94(3), 135–140. https://pubmed.ncbi.nlm.nih.gov/7778330/
Carpenter, K. M., Miele, G., & Hasin, D. S. (2002). Does motivation to change mediate
the effect of DSM-IV substance use disorders on treatment utilization and
substance use. Addictive Behaviors, 27(2), 207–225. doi:10.1016/s03064603(00)00178-7
Collins, S. E., Malone, D. K, & Larimer, M. E. (2012). Motivation to change and
treatment attendance as predictors of alcohol-use outcomes among project-based
Housing First residents. Addictive Behaviors, 37(8), 931–939.
doi:10.1016/j.addbeh.2012.03.029
Copeland, J., Swift, W., Roffman, R., & Stephens, R. (2001). A randomized controlled
trial of brief cognitive-behavioral interventions for cannabis use disorder. Journal
of Substance Abuse Treatment, 21(2), 55–64. doi:10.1016/s0740-5472(01)00179-

88
9
Couwenbergh, C., Van Der Gaag, R. J., Koeter, M., De Ruiter, C., & Van Den Brink, W.
(2009). Screening for substance abuse among adolescents: Validity of the CAGEAID in youth mental health care. Substance Use and Misuse, 44(6), 823–834.
https://doi.org/10.1080/10826080802484264
Creswell, J. (2009). Research design: Qualitative, quantitative, and mixed methods
approaches (Laureate Education, Inc., custom ed.). Thousand Oaks, CA: Sage.
Cunningham, R., Bernstein, S., Walton, M., et al. (2009). Alcohol, tobacco, and other
drugs: Future directions for screening and intervention in the emergency
department. Academic Emergency Medicine, 16(11), 1078–1088.
doi:10.1111/j.1553-2712.2009.00552.x
Darke, S., Duflou, J., & Kaye, S. (2017). Prevalence and nature of cardiovascular disease
in methamphetamine-related death: A national study. Drug and Alcohol
Dependence, 179, 174–179. doi:10.1016/j.drugalcdep.2017.07.001
Derlet, R., Albertson, T. E., & Rice, P. (1990). Protection against D-amphetamine
toxicity. The American Journal of Emergency Medicine, 8(2), 105–108.
https://doi.org/10.1016/0735-6757(90)90194-5
DiClemente, C. (2018). Addiction and change: How addictions develops and addicted
people recover (2nd ed.). New York, NY: The Guilford Press.
DiClemente, C., Schlundt, D., & Gemmell, L. (2004). Readiness and stages of change in
addiction treatment. The American Journal on Addictions, 13(2), 103–
119. doi:10.1080/10550490490435777

89
Diercks, D., Fonarow, G., Kirk, J., Jois-Bilowich, P., Hollander, C., Weber, J., &
Peacock, W.(2008). Illicit stimulant use in a United States heart failure population
presenting to the emergency department (from the Acute Decompensated Heart
Failure National Registry Emergency Module). The American Journal of
Cardiology, 102(9), 1216–1219.
doi:http://dx.doi.org/10.1016/j.amjcard.2008.06.045
De Micheli, D., Fisberg, M., & Formigoni M. L. (2004). Study on the effectiveness of
brief intervention for alcohol and other drug use directed to adolescents in a
primary health care unit. Revista da Associacao Medica Brasileira, 50(3), 305–
313. doi:10.1590/s0104-42302004000300040
D’Onofrio, G., & Degutis, L. C. (2002). Preventive care in the emergency department:
Screening and brief intervention for alcohol problems in the ED: A systematic
review. Academic Emergency Medicine, 9(6), 627–638. doi:10.1111/j.15532712.2002.tb02304.x
Dwinnells, R. (2015). SBIRT as a vital sign for behavioral health identification,
diagnosis, and referral in community health care. Annals of Family Medicine,
13(3), 261–263. doi:10.1370/afm.1776
Ewing, J. A. (1984). Detecting alcoholism: the CAGE questionnaire. Journal of the
American Medical Association, 252(14), 1905–1907.
doi:10.1001/jama.252.14.1905
Faul, F., Erdfelder, E., Lang, A. G., & Buchner, A. (2013). Power 3: A flexible statistical
power analysis program for the social, behavioral, and biomedical sciences.

90
Behavior Research Methods, 39, 175–191. https://doi.org/10.3758/BF03193146
Fiellin, D. A., Reid, M. C., & O’Connor, P. G. (2000). Screening for alcohol problems in
primary care: A systematic review. Behavior Research Methods, 39, 175–
191. https://doi.org/10.3758/BF03193146
Fleming, M. F., Barry, K. L., Manwell, L. B., Johnson, K., & London, R. (1997). Brief
physician advice for problem alcohol drinkers: a randomized controlled trial in
community-based primary care practices. Journal of the American Medical
Association, 277(13), 1039–1045. doi:10.1001/jama.1997.03540370029032
Fowler, J. S., Volkow, N. D., Logan, J., Alexoff, D., Telang, F., Wang, G.-J., Wong, C.,
Ma, Y., Kriplani, A., Pradhan, K., Schlyer, D., Jayne, M., Hubbard, B., Carter, P.,
Warner, D., King, P., Shea, C., Xu, Y., Muench, L., & Apelskog, K. (2008). Fast
uptake and long-lasting binding of methamphetamine in the human brain:
Comparison with cocaine. NeuroImage, 43(4), 756–763.
https://doi.org/10.1016/j.neuroimage.2008.07.020
Gelberg, L., Andersen, R. M., Afifi, A. A., Leake, B. D., Arangua, L., Vahidi, M.,
Singleton, K., Yacenda-Murphy, J., Shoptaw, S., Fleming, M. F., & Baumeister,
S. E. (2015). Project QUIT (Quit Using Drugs Intervention Trial): A randomized
controlled trial of a primary care-based multi-component brief intervention to
reduce risky drug use. Addiction (Abingdon, England), 110(11), 1777–1790.
doi:10.1111/add.12993
Gentilello, L., Rivara, P., Donovan, M., Jurkovich, G., Daranciang, E., Dunn, C., . . .
Ries, R. (1999). Alcohol interventions in a trauma center as a means of reducing

91
the risk of injury recurrence. Annals of Surgery, 230(4), 473–484.
doi:10.1097/00000658-199910000-00003
Glass, J. E., Andréasson, S., Bradley, K. A., Finn, S. W., Williams, E. C., Bakshi, A.-S.,
Gual, A., Heather, N., Sainz, M. T., Benegal, V., & Saitz, R. (2017). Rethinking
alcohol interventions in health care: A thematic meeting of the International
Network on Brief Interventions for Alcohol & Other Drugs (INEBRIA).
Addiction Science and Clinical Practice, 12(14), 1–16. doi:10.1186/s13722-0170079-8
Hanewinkel, R., & Wiborg, G. (2005). Brief alcohol screening and intervention for
college students (BASICS): A German pilot study. Sucht: Zeitschrift für
Wissenchaft und Praxis, 51(5), 285–290. doi:10.1024/2005.05.05
Hansen, K. A., McKernan, L. C., Carter, S. D., Allen, C., & Wolever, R. Q. (2019). A
replicable and sustainable whole person care model for chronic pain. Journal of
Alternative and Complementary Medicine, 25(1), 86–94.
doi:10.1089/acm.2018.0420
Hersh, A. M., Masoudi, F. A., & Allen, L. A. (2013). Postdischarge environment
following heart failure hospitalization: expanding the view of hospital
readmission. Journal American Heart Association, 2(2), 1–14.
doi:10.1161/JAHA.113.000116.
Horsley, L. (2010). ACC and AHA update on chronic heart failure guidelines. American
Family Physician, 81(5), 654–665.
http://circ.ahajournals.org/cgi/content/full/119/14/1977

92
Hosmer, D. W., Lemeshow, S., & Sturdivant, R. X. (2013). Applied logistic regression
(3rd ed.). Hoboken, NJ: John Wiley & Sons.
Humeniuk, R., Ali, R., Babor, T., Souza-Formigoni, M. L., de Lacerda, R. B., Ling, W.,
McRee, B., Newcombe, D., Pal, H., Poznyak, V., Simon, S., & Vendetti, J.
(2012). A randomized controlled trial of a brief intervention for illicit drugs
linked to the Alcohol, Smoking and Substance Involvement Screening Test
(ASSIST) in clients recruited from primary health-care settings in four
countries. Addiction, 107(5), 957–966. doi:10.1111/j.1360-0443.2011.03740.x
Kaner, E. F., Dickinson, H. O., Beyer, F., Pienaar, E., Schlesinger, C., Campbell, F.,
Saunders, J. B., Burnand, B., & Heather, N. (2009). The effectiveness of brief
alcohol interventions in primary care settings: a systematic review. Drug Alcohol
Review, 28(3), 301–323. doi:10.1111/j.1465-3362.2009.00071.x
Karch, S. (2007). The unique histology of methamphetamine cardiomyopathy: A case
report. Forensic Science International, 212(1-3), 1–4.
doi:10.1016/j.forsciint.2011.04.028
Kaye, S., McKetin, R., Duflou, J., & Darke, S. (2007). Methamphetamine and
cardiovascular pathology: A review of the evidence. Addiction, 102(8), 1204–
1211. doi:10.1111/j.1360-0443.2007.01874.x
Kennedy, K., & Gregoire, T. (2009). Theories of motivation in addiction treatment:
Testing the relationship of the transtheoretical model of change and selfdetermination theory. Journal of Social Work Practice in the Addictions, 9(2),
163–183. https://doi.org/10.1080/15332560902852052

93
Kunz, F. M. Jr, French, M. T., & Bazargan-Hejazi, S. (2004). Cost-effectiveness analysis
of a brief intervention delivered to problem drinkers presenting at an inner-city
hospital emergency department. Journal of Studies on Alcohol, 65(3), 363–70.
doi:10.15288/jsa.2004.65.363
Logan, B. K., Fligner, C. L., & Haddix, T. (1998). Cause and manner of death in fatalities
involving methamphetamine. Journal of Forensic Sciences, 43(1), 28–34.
doi:10.1520/JFS16085J.
Madras, B. K., Compton, W. M., Avula, D., Stegbauer, T., Stein, J. B., & Clark, H. W.
(2008). Screening, brief interventions, referral to treatment (SBIRT) for illicit
drug and alcohol use at multiple healthcare sites: Comparison at intake and 6
months later. Drug Alcohol Dependence, 99(1-3), 280–295.
doi:10.1016/j.drugalcdep.2008.08.003
Marlatt, G. A., Witkiewitz, K., Dillworth, T. M., Bowen, S. W., Parks, G. A.,
Macpherson, L. M., Lonczak, H. S., Larimer, M. E., Simpson, T., Blume, A &
Crutcher, W. (2004). Vipassana meditation as a treatment for alcohol and drug
use disorders. In S. C. Hayes, V. M. Follette, & M. M. Linehan (Eds.),
Mindfulness and acceptance: Expanding the cognitive-behavioral tradition (pp.
261–287). New York, NY: The Guilford Press.
Marshall, S. J., & Biddle, S. J. H. (2001). The transtheoretical model of behavior change:
A meta-analysis of applications to physical activity and exercise. Annals of
Behavioral Medicine, 23(4), 229–246.
https://doi.org/10.1207/S15324796ABM2304_2

94
Martens, M. P., Cimini, M. D., Barr, A. R., Rivero, E. M., Vellis, P.A., Desemone, G. A.,
& Horner, K. J. (2007). Implementing a screening and brief intervention for highrisk drinking in university-based health and mental health care settings:
Reductions in alcohol use and correlates of success. Addictive Behaviors, 32(11),
2563–2572. doi:10.1016/j.addbeh.2007.05.005
Mayfield, D., McLeaod, G., & Hall, P. (1974). The CAGE questionnaire: Validation of a
new alcoholism screening instrument. American Journal of Psychiatry, 131(10),
1121–1123. doi:10.1176/ajp.131.10.1121
McKetin, R., Dawe, S., Burns, R., Hides, L., Kavanagh, D., Teeson, M., McYoung, R., &
Saunders, J. (2016). The profile of psychiatric symptoms exacerbated by
methamphetamine use. Drug and Alcohol Dependence, 161, 104–109.
doi:10.1016/j.drugalcdep.2016.01.018
Mee-Lee, D. (2013). The ASAM criteria: Treatment criteria for addictive, substancerelated, and co-occurring conditions (3rd ed.). Chevy Chase, MD: American
Society of Addiction Medicine, Inc.
Migneault, J., Adams, T., & Read, J. (2005). Application of the transtheoretical model to
substance abuse: historical development and future directions. Drug and Alcohol
Review, 24(5), 437–448. doi:10.1080/09595230500290866
Miller, W. R., & Rollnick, S. (2012). Motivational interviewing: Helping people for
change (3rd ed.). New York, NY: The Guilford Press.
Montgomery, D. C., Peck, E. A., & Vining, G. G. (2014). Introduction to linear
regression analysis. Hoboken, NJ: John Wiley & Sons.

95
Moyer, A., Finney, J., Swearingen, C., & Vergun, P. (2002). Brief interventions for
alcohol problems: A meta-analytic review of controlled investigations in
treatment-seeking and non-treatment-seeking populations. Addiction, 97(3), 279–
292. doi:10.1046/j.1360-0443.2002.00018.x
Moyer, V. A. (2013). Screening and behavioral counseling interventions in primary care
to reduce alcohol misuse: U.S. Preventive Services Task Force Recommendation
Statement. https://doi.org/10.7326/0003-4819-159-3-201308060-00652
Murphy, J. G., Duchnick, J. J., Vuchinich, R. E., Davison, J. W., Karg, R. S., Olson, A.
M., Smith, A. F., & Coffey, T. T. (2001). Relative efficacy of a brief motivational
intervention for college student drinkers. Psychology of Addictive Behaviors,
15(4), 373–379. doi:10.1037//0893-164x.15.4.373
National Association of Social Workers (NASW). (2014). Standards for social work
practice in healthcare setting. Washington, D.C.: NASW Press. National Institute
on Drug Abuse. Trends & Statistics. https://drugabuse.gov/related-topics/trendsstatictics5
NIDA. (2013). Methamphetamine. drugabuse.gov, April 8.
https://drugabuse.gov/publications/research-reports/methamphetamine on 2018
Paratz, E., Cunningham, N., & MacIsaac, A. (2016). The cardiac complications of
methamphetamines. Heart, Lung and Circulation, 25, 325–332.
doi:10.1016/j.hlc.2015.10.019
Prochaska, J. O., DiClemente, C. C., & Norcross, J. C. (1992). In search of how people
change: Applications to the addictive behaviors. American Psychologist, 47(9),

96
1102–1114. doi:10.1037//0003-066x.47.9.1102
Quanbeck, A., Lang, K., Enami, K., & Brown, R. L. (2010). A cost-benefit analysis of
Wisconsin's screening, brief intervention, and referral to treatment program:
Adding the employer’s perspective. State Medical Society of Wisconsin, 109(1),
9–14. https://wmjonline.org/wp-content/uploads/2010/109/1/9.pdf
Richards, J., Harms, B., Kelly, A., & Turnipseed, S. (2018). Methamphetamine use and
heart failure: Prevalence, risk factors, and predictors. American Journal of
Emergency Medicine, 36(8), 1423–1428. doi:10.1016/j.ajem.2018.01.001
Roy-Byrne, M., Bumgardner, K., Krupski, A., Dunn, C., Ries, R., Donovan, D., West, I.
I., Maynard, C., Atkins, D. C., Graves, M. C., Joesch, J. M., & Zarkin, G. A.
(2014). Brief intervention for problem drug us in safety-net primary care settings.
A randomized clinical trial. The Journal of the American Medical Association,
312(5), 492–501. doi:10.1001/jama/2014.7860
Saitz, R. (2014). Screening and brief intervention for unhealthy drug use: Little or no
efficacy. Front Psychiatry, 2(5), 121–130. doi:10.3389/fpsyt.2014.00121
Saitz, R., Alford, D. P., Bernstein, J. A., Cheng, D. M., Samet, J., & Palfai, T. P. A.
(2010). Screening and brief intervention for unhealthy drug use in primary care
settings: Randomized clinical trials are needed. Journal of Addiction
Medicine, 4(3), 123–130. http://doi.org/10.1097/ADM.0b013e3181db6b67
Saitz, R., Palfai, T. P. A., Cheng, D. M., Alford, D. P., Bernstein, J. A., Lloyd-Travaglini,
C. A., Meli, S. M., Chaisson, C. E., & Samet, J. (2012). Screening and brief
intervention for drug use in primary care: The ASPIRE randomized clinical trial.

97
The Journal of the American Medical Association, 312(5), 123–130.
doi:10.1001/jama2014.7862
Schulte, M. T., & Hser, Y. (2014). Substance use and associated health conditions
throughout the life span. Public Health Reviews, 35(2), 1–27.
doi:10.1007/BF03391702
Smith, P. C., Schmidt, S. M., Allensworth-Davies, D., & Saitz, R. (2010). A singlequestion screening test for drug use in primary care. Archives of Internal
Medicine, 170(13), 1155–1160. doi:10.1001/archinternmed.2010.140
Stanford, M. (2009). Foundations in behavioral pharmacology: An introduction to the
neuroscience of drug addiction and mental disorders. Santa Cruz, CA: Lightway
Centre.
Stanford, M., & Avoy, D. (2006). Professional perspectives on addiction medicine:
Understanding opioid addiction and the function of methadone treatment. San
Jose, CA: Santa Clara Valley Health & Hospital System Department of Alcohol
and Drug Services Addiction Medicine and Therapy Division.
Substance Abuse and Mental Health Services Administration. (2011). Screening, brief
intervention and referral to treatment (SBIRT) in behavioral health.
http://samhsa.gov/sites/default/files/sbirtwhitepaper_opdf
Substance Abuse and Mental Health Services Administration. (n.d.). Results from the
2015 National Survey on Drug Use and Health: Summary of national findings.
NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville, MD:
Substance Abuse and Mental Health Services Administration.

98
Simon, M. K. (2011). Dissertation and scholarly research: Recipe for success. Seattle,
WA: Dissertation Success LLC.
Swaminathan, A., Aggarwal, M., Wang, C., Marlatt, C., Dang, L., Huang, Y. C., . . .
Kelton, D. (2014). Multidisciplinary approach to heart failure patients: Focus on
transition of care and readmission rates. Santa Clara Valley Medical Center.
Tarango, N., & Baird, A. (2018). Managing the patient with pulmonary arterial
hypertension and methamphetamine use: A practical perspective for the clinician.
Advances in Pulmonary Hypertension, 17(2), 55–62.
https://doi.org/10.21693/1933-088X-17.2.55
Timko, C., Kong, C., Vittorio, L., & Cucciare, M. A. (2016). Screening and brief
intervention for unhealthy substance use in patients with chronic medical
conditions: A systematic review. Journal of Clinical Nursing, 25, 3131–3143.
doi:10.1111/jocn.13244
Toumbourou, J. W., Stockwell, T., Neighbors, C., Marlatt, G. A., Sturge, J., & Rehm, J.
(2007). Interventions to reduce harm associated with adolescent substance use.
The Lancet (ScienceDirect), 69(9570), 1391–1401. doi:10.1016/S01406736(07)60369-9
United Nations Office on Drugs and Crime (UNODC). (2017). World drug report.
http://unodc.org
U.S. Preventive Services Task Force (USPSTF). (2004). Screening and behavioral
counseling interventions in primary care to reduce alcohol misuse:
Recommendation statement. Annals of Internal Medicine, 140(7), 554–556.

99
doi:10.7326/0003-4819-159-3-201308060-00652
Whitlock, E. P., Polen, M. R., Green, C. A., Orleans, T., Klein, J. (2004). Behavioral
counseling interventions in primary care to reduce risky/harmful alcohol use by
adults: A summary of the evidence for the U.S. Preventive Services Task
Force. Annals of Internal Medicine, 140(7), 557–568. doi:10.7326/0003-4819140-7-200404060-00017
Wijetunga, M., Seto, T., Lindsay, J., & Schatz, I. (2003). Crystal methamphetamineassociated cardiomyopathy: Tip of the iceberg? Journal of Toxicology, 41(7),
981–986. doi:10.1081/CLT-120026521
Yardley, L. (2017). Demonstrating the validity of qualitative research. The Journal of
Positive Psychology, 12(3), 295–296.
http://dx.doi.org.ezp.waldenulibrary.org/10.1080/17439760.2016.1262624
Yeo, K.-K., Wijetunga, M., Ito, H., Efird, J. T., Tay, K., Seto, T. B., Alimineti, K.,
Kimata, C., & Schatz, I. J. (2007). The association of methamphetamine use and
cardiomyopathy in young patients. The American Journal of Medicine, 120(2),
165–171. doi:http://dx.doi.org/10.1016/j.amjmed.2006.01.024
Zgierska, A., Amaza, I., Brown, M., & Fleming, M. (2014). Unhealthy drug use: how to
screen, when to intervene. The Journal of Family Practice, 63(9), 524–530.
https://cdn.mdedge.com/files/s3fs-public/Document/September2017/JFP_06309_Article3.pdf

